<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78662</article-id><article-id pub-id-type="doi">10.7554/eLife.78662</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>CXCR4<sup>high</sup> megakaryocytes regulate host-defense immunity against bacterial pathogens</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-274390"><name><surname>Wang</surname><given-names>Jin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4924-1716</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-274391"><name><surname>Xie</surname><given-names>Jiayi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8977-6654</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-274392"><name><surname>Wang</surname><given-names>Daosong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4786-6202</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-274393"><name><surname>Han</surname><given-names>Xue</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274394"><name><surname>Chen</surname><given-names>Minqi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-274395"><name><surname>Shi</surname><given-names>Guojun</given-names></name><email>shigj6@mail.sysu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-163636"><name><surname>Jiang</surname><given-names>Linjia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8854-2610</contrib-id><email>jianglj7@mail.sysu.edu.cn</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-165007"><name><surname>Zhao</surname><given-names>Meng</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7909-7594</contrib-id><email>zhaom38@mail.sysu.edu.cn</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tm3k558</institution-id><institution>Department of Endocrinology &amp; Metabolism, The Third Affiliated Hospital, Sun Yat-sen University</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01px77p81</institution-id><institution>RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0064kty71</institution-id><institution>Key Laboratory of Stem Cells and Tissue Engineering, Zhongshan School of Medicine, Sun Yat-sen University, Ministry of Education</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rehman</surname><given-names>Jalees</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02mpq6x41</institution-id><institution>University of Illinois at Chicago</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>van der Meer</surname><given-names>Jos W</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05wg1m734</institution-id><institution>Radboud University Medical Centre</institution></institution-wrap><country>Netherlands</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>29</day><month>07</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e78662</elocation-id><history><date date-type="received" iso-8601-date="2022-03-15"><day>15</day><month>03</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-07-28"><day>28</day><month>07</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-06-10"><day>10</day><month>06</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.06.09.447810"/></event></pub-history><permissions><copyright-statement>© 2022, Wang, Xie, Wang et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Wang, Xie, Wang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78662-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-78662-figures-v2.pdf"/><abstract><p>Megakaryocytes (MKs) continuously produce platelets to support hemostasis and form a niche for hematopoietic stem cell maintenance in the bone marrow. MKs are also involved in inflammatory responses; however, the mechanism remains poorly understood. Using single-cell sequencing, we identified a CXCR4 highly expressed MK subpopulation, which exhibited both MK-specific and immune characteristics. CXCR4<sup>high</sup> MKs interacted with myeloid cells to promote their migration and stimulate the bacterial phagocytosis of macrophages and neutrophils by producing TNFα and IL-6. CXCR4<sup>high</sup> MKs were also capable of phagocytosis, processing, and presenting antigens to activate T cells. Furthermore, CXCR4<sup>high</sup> MKs also egressed circulation and infiltrated into the spleen, liver, and lung upon bacterial infection. Ablation of MKs suppressed the innate immune response and T cell activation to impair the anti-bacterial effects in mice under the <italic>Listeria monocytogenes</italic> challenge. Using hematopoietic stem/progenitor cell lineage-tracing mouse lines, we show that CXCR4<sup>high</sup> MKs were generated from infection-induced emergency megakaryopoiesis in response to bacterial infection. Overall, we identify the CXCR4<sup>high</sup> MKs, which regulate host-defense immune response against bacterial infection.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>hematopoietic stem cell</kwd><kwd>host-defense immunity</kwd><kwd>megakaryocytes</kwd><kwd>megakaryopoiesis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012166</institution-id><institution>National Key Research and Development Program of China</institution></institution-wrap></funding-source><award-id>2018YFA0107200</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Meng</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82170112</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Meng</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81900101</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Jin</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Key Research and Development Program of Guangdong Province</institution></institution-wrap></funding-source><award-id>2019B020234002</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Meng</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012541</institution-id><institution>Guangdong Innovative and Entrepreneurial Research Team Program</institution></institution-wrap></funding-source><award-id>2016ZT06S029</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Meng</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012541</institution-id><institution>Guangdong Innovative and Entrepreneurial Research Team Program</institution></institution-wrap></funding-source><award-id>2019ZT08Y485</award-id><principal-award-recipient><name><surname>Jiang</surname><given-names>Linjia</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012151</institution-id><institution>Sanming Project of Medicine in Shenzhen</institution></institution-wrap></funding-source><award-id>SZSM201911004</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Meng</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002858</institution-id><institution>China Postdoctoral Science Foundation</institution></institution-wrap></funding-source><award-id>2021M693614</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Jin</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>scRNA-seq identified CXCR4<sup>high</sup> MKs can funtionally regulate host-defense immune response against bacterial infection.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Megakaryocytes (MKs) are large and rare hematopoietic cells in the bone marrow, which continually produce platelets to support hemostasis and thrombosis (<xref ref-type="bibr" rid="bib18">Deutsch and Tomer, 2006</xref>). MK progenitors undergo multiple rounds of endomitosis during maturation to achieve polyploidy (<xref ref-type="bibr" rid="bib11">Chang et al., 2007</xref>; <xref ref-type="bibr" rid="bib19">Deutsch and Tomer, 2013</xref>; <xref ref-type="bibr" rid="bib46">Machlus and Italiano, 2013</xref>; <xref ref-type="bibr" rid="bib49">Nagata et al., 1997</xref>; <xref ref-type="bibr" rid="bib57">Patel et al., 2005</xref>). MKs and their progenitors migrate between distinct microenvironments and organs for their proliferation, maturation, and biological functions (<xref ref-type="bibr" rid="bib3">Avecilla et al., 2004</xref>; <xref ref-type="bibr" rid="bib27">Fuentes et al., 2010</xref>; <xref ref-type="bibr" rid="bib43">Lefrançais et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">Pal et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Tamura et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Wang et al., 1998</xref>). Although platelet generation is the prominent role of MKs, emerging evidence suggests that MKs have other biological functions. Mature MKs interact with HSCs and constitute a unique niche to preserve HSC quiescence in the bone marrow (<xref ref-type="bibr" rid="bib8">Bruns et al., 2014</xref>; <xref ref-type="bibr" rid="bib84">Zhao et al., 2014</xref>). MKs also interact with other niche cells, such as osteoblasts (<xref ref-type="bibr" rid="bib20">Dominici et al., 2009</xref>; <xref ref-type="bibr" rid="bib53">Olson et al., 2013</xref>), non-myelinating Schwann cells (<xref ref-type="bibr" rid="bib36">Jiang et al., 2018</xref>; <xref ref-type="bibr" rid="bib79">Yamazaki et al., 2011</xref>), and blood vessels (<xref ref-type="bibr" rid="bib3">Avecilla et al., 2004</xref>; <xref ref-type="bibr" rid="bib61">Saçma et al., 2019</xref>) to further influence the attraction and retention of hematopoietic stem and progenitor cells during homeostasis and stress.</p><p>MK-biased hematopoietic stem cells (HSCs) induce emergency megakaryopoiesis to actively generate MKs upon acute inflammation, which can efficiently replenish the platelet loss during inflammatory insult (<xref ref-type="bibr" rid="bib29">Haas et al., 2015</xref>). Studies suggested that MKs might participate in immune responses independent of their platelet generation role (<xref ref-type="bibr" rid="bib15">Cunin and Nigrovic, 2019</xref>). MKs express multiple immune receptors, such as IgG Fc receptors and toll-like receptors (TLRs), enabling them to sense inflammation directly (<xref ref-type="bibr" rid="bib15">Cunin and Nigrovic, 2019</xref>). Mature MKs also express major histocompatibility complex (MHC) to activate antigen-specific CD8<sup>+</sup> T cells and enhance CD4<sup>+</sup> T cells and Th17 cell responses through stimulating antigen processing (<xref ref-type="bibr" rid="bib26">Finkielsztein et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib85">Zufferey et al., 2017</xref>). Furthermore, MKs release multiple cytokines and chemokines to influence immune cells. For example, MKs produce IL-1α and IL-1β to promote arthritis susceptibility in mice resistant to arthritis (<xref ref-type="bibr" rid="bib14">Cunin et al., 2017</xref>) and produce CXCL1 and CXCL2 to promote neutrophil efflux from the bone marrow (<xref ref-type="bibr" rid="bib42">Köhler et al., 2011</xref>). Lung MKs contribute to thrombosis (<xref ref-type="bibr" rid="bib43">Lefrançais et al., 2017</xref>) and, more interestingly, participate in immune responses (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>), although the relationship between lung MKs and bone marrow circulating MKs (<xref ref-type="bibr" rid="bib52">Nishimura et al., 2015</xref>) remains unexplored. Furthermore, the recent single-cell atlas shows that MKs are heterogeneous and contain subpopulations that express multiple immune genes and are involved in inflammation response (<xref ref-type="bibr" rid="bib45">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>). Here, by combining scRNA-seq with functional assays, we identified a CXCR4<sup>high</sup> MK population, which was generated by infection-induced emergency megakaryopoiesis, and stimulated innate immunity against bacterial infection.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Single-cell atlas identifies an immune-modulatory subpopulation of MKs</title><p>We applied droplet-based scRNA-seq with CD41<sup>+</sup> forward scatter (FSC)<sup>high</sup> bone marrow MKs to explore the MK heterogeneity (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A,B</xref>). To enrich accurate MKs, we further performed transcriptomic profile analysis in the phenotypically enriched MKs (<xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>). Our scRNA-seq successfully detected 5368 high-quality cells (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B,C</xref>), in which one MK cluster (1712 cells) and six immune cell clusters (3656 cells) were annotated according to their gene profile (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D-G</xref>) and the alignment with published scRNA-seq data (<xref ref-type="bibr" rid="bib2">Almanzar et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Hamey et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Xie et al., 2020</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>). Our annotated MKs were similar to MKs but distinct to immune cells, including myeloid progenitors, basophils, neutrophils, monocytes, dendritic cells, macrophages, B cells, and T cells, in an integrated scRNA-seq analysis platform (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Therefore, we re-clustered the transcriptionally enriched 1712 MKs into five subpopulations, termed MK1 to MK5 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A,B</xref>), which were further confirmed by the integrated scRNA-seq analysis platform to rule out the potential immune cell contamination (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Xie et al., 2020</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>; <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C,D</xref>). We noticed that mature MKs with huge sizes were captured at a relatively low rate, potentially due to the limitation in current techniques in cell purification and single-cell preparation (<xref ref-type="bibr" rid="bib45">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Sun et al., 2021</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Single-cell atlas identifies an immune-modulatory subpopulation of MKs.</title><p>(<bold>A</bold>) Schematic strategy for MK preparation, scRNA-seq and data analysis. (<bold>B</bold>) Clustering of 1712 bone marrow MKs. (<bold>C</bold>) Heatmap of signature gene expression in MK subpopulations (fold-change &gt;1.5, p value &lt;0.05) with exemplar genes listed on the right (top, color-coded by subpopulations). Columns denote cells; rows denote genes. Z score, row-scaled expression of the signature genes in each subpopulation. (<bold>D</bold>) Gene Ontology (GO) analysis of signature genes (fold-change &gt;1.5, p value &lt;0.05) for each MK subpopulations. GO terms selected with Benjamini–Hochberg-corrected p values &lt;0.05 and colored by –log<sub>10</sub>(p value). Bubble size indicates the enriched gene number of each term. (<bold>E–F</bold>) UMAP visualization (<bold>E</bold>) and statistical analysis (<bold>F</bold>) of cytokine score (left), inflammatory score (middle) and chemokine score (right) in MK1 to 5. (<bold>G</bold>) Dotplots of significant cytokine ligand (source) -receptor (target) interactions between MKs and immune cells discovered. The color indicates the means of the receptor-ligand pairs between two cell types and bubble size indicates p values. Mon, monocytes; MΦ, macrophages (<xref ref-type="bibr" rid="bib21">Dong et al., 2020</xref>); DC, dendritic cells; Neu, neutrophils; MP, myeloid progenitors; T, T cells; B, B cells. (<bold>H–I</bold>) Violin plot (<bold>H</bold>) and feature plot (<bold>I</bold>) of selected signature genes of MK5. Red lines in (<bold>H</bold>) indicate the median gene expression. Repeated-measures one-way ANOVA followed by Dunnett’s test for multiple comparisons in (<bold>F</bold>), ǂǂ &lt;0.01, ǂǂǂ p&lt;0.001.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Signature genes of MK1 to MK5.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78662-fig1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>The means and p value of the average expression level of interacting molecule 1 in cluster 1 and interacting molecule 2 in cluster 2 by CellPhoneDB.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78662-fig1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Cell isolation, quality control and annotation of scRNA-seq data.</title><p>(<bold>A</bold>) Flow cytometry gating for isolation of MKs (CD41<sup>+</sup> FSC<sup>high</sup>) in bone marrow for scRNA-seq. (<bold>B</bold>) Quality control of scRNA-seq data. Violin plots showing the number of unique genes (gene number) before and after removing doublets, number of total unique molecular identifiers (UMI counts) and percentage of mitochondrial transcripts in single cells after removing doublets. Scatter plot showing the correlation between UMI counts and gene numbers. corr indicates Pearson correlation coefficient. (<bold>C–D</bold>) UMAP of 5368 bone marrow cells, colored by gene numbers (<bold>C</bold>) and by cluster identity indicated on the right (<bold>D</bold>). MK, megakaryocytes; Neu, neutrophils; MΦ, macrophages; MP, myeloid progenitors; DC, dendritic cells; Mon, monocytes; B, B cells; T, T cells. (<bold>E</bold>) Heatmap of row-scaled signature gene expression in each cell type (top, color-coded by subpopulations). Columns denote cells; rows denote genes. Z score, row-scaled expression of the signature genes in each subpopulation. (<bold>F</bold>) Feature plots showing selected gene expression. (<bold>G</bold>) Violin plots showing the number of unique genes (gene number) of 1712 MKs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Cell type identification by alignment with published scRNA-seq data.</title><p>(<bold>A</bold>) Radar charts showing cell similarities of our single cell dataset with the published bone marrow MK single cells (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>), bone marrow immune cells and myeloid progenitor single cells (<xref ref-type="bibr" rid="bib2">Almanzar et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Hamey et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Xie et al., 2020</xref>) using MetaNeighbor R package. (<bold>B</bold>) Comparison of our bone marrow scRNA-seq data with published bone marrow MK (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>) and immune cell (<xref ref-type="bibr" rid="bib2">Almanzar et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Hamey et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Xie et al., 2020</xref>) datasets. All cells were integrated by iMAP.py and projected on UMAP. (<bold>C</bold>) Column-scaled Euclidean distances between the centroid of each cluster. Z score, column-scaled Euclidean distance. MK, megakaryocytes; Neu, neutrophils; MΦ, macrophages; MP, myeloid progenitors; DC, dendritic cells; Mon, monocytes; B, B cells; T, T cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Identification of MK subpopulations.</title><p>(<bold>A</bold>) Re-clustering of 1712 MKs from 5368 cells. (<bold>B</bold>) Violin plots showing MK marker gene expression (<xref ref-type="bibr" rid="bib1">Aburima et al., 2021</xref>; <xref ref-type="bibr" rid="bib5">Bernardes et al., 2020</xref>; <xref ref-type="bibr" rid="bib38">Kanaji et al., 2005</xref>; <xref ref-type="bibr" rid="bib45">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib12">Couldwell and Machlus, 2019</xref>; <xref ref-type="bibr" rid="bib54">Ozaki et al., 2005</xref>; <xref ref-type="bibr" rid="bib68">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>) of MK1 to 5. Red lines indicate the median gene expression. (<bold>C</bold>) Projection of our datasets on reported MK (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>) and immune cell (<xref ref-type="bibr" rid="bib31">Hamey et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Xie et al., 2020</xref>) scRNA-seq datasets by Symphony R package. MK, megakaryocytes; Neu, neutrophils; MΦ, macrophages; MP, myeloid progenitors; DC, dendritic cells; Mon, monocytes; Bas, basophils; B, B cells; T, T cells; ABM, adult bone marrow. (<bold>D</bold>) MKs (MK1 to 5) and cell types projection based on similarities of our single-cell transcriptional profiles and published MK (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>) and immune cell datasets (<xref ref-type="bibr" rid="bib31">Hamey et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Xie et al., 2020</xref>) by scmap R package.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Enriched genes in MK1 to 4 and MK5.</title><p>(<bold>A</bold>) Volcano plot showing MK5 and MK1 to 4 enriched genes (|fold change|&gt;1.4, p value &lt;0.05). (<bold>B–C</bold>) Gene Ontology (GO) analysis showing MK5 enriched immune pathway genes and MK1 to 4 mainly enriched hemopoiesis and RNA processing pathway genes. (<bold>D–F</bold>) Gene set enrichment analysis (GSEA) evaluated enrichment of selected pathways in MK5 cells compared to other MK subpopulations (MK1 to 4).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig1-figsupp4-v2.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 5.</label><caption><title>MK5 interacts with immune cells and express signature genes of immune MKs.</title><p>(<bold>A</bold>) Dotplots of significant cytokine ligand (source) -receptor (target) interactions between MKs and immune cells discovered using CellChat. Color indicates communication probabilities, and bubble size indicates p value of the ligand-receptor pairs between MK subpopulations (source) and immune cells (target). (<bold>B</bold>) Selected signature gene expression in MK subpopulations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig1-figsupp5-v2.tif"/></fig><fig id="fig1s6" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 6.</label><caption><title>Polyploidy, platelet generation ability and cell size of CXCR4<sup>low</sup> and CXCR4<sup>high</sup> MKs.</title><p>(<bold>A</bold>) Representative flow cytometry plots of gating strategy of CD41 and CXCR4 in the bone marrow of control mice and mice 3 days after <italic>L. monocytogenes</italic> infection. (<bold>B</bold>) Relative expression of <italic>Pf4</italic>, <italic>Vwf</italic> and <italic>Mpl</italic> in CXCR4<sup>high</sup> and CXCR4<sup>low</sup> MKs by RT-qPCR. (<bold>C</bold>) Representative immunofluorescent staining image showing membranous CD41 staining typical of sorted bone marrow CXCR4<sup>high</sup> MKs. (<bold>D</bold>) Sorted CXCR4<sup>low</sup> and CXCR4<sup>high</sup> MKs produced proplatelets in vitro on day five post cultured under 100 ng ml<sup>–1</sup> TPO. White arrowheads indicate proplatelet formation. (<bold>E</bold>) Polyploidy distribution of CXCR4<sup>low</sup> MKs and CXCR4<sup>high</sup> MKs (right). (<bold>F</bold>) Representative immunofluorescent staining images showing CD41 and CXCR4 expression of CXCR4<sup>low</sup> and CXCR4<sup>high</sup> MKs in the bone marrow. CD41, green; CXCR4, red; DAPI, blue. (<bold>G</bold>) Comparison of cell size between CXCR4<sup>low</sup> MKs and CXCR4<sup>high</sup> MKs on day three post cultured under 100 ng ml<sup>–1</sup> Thrombopoietin (TPO). (<bold>H</bold>) Median fluorescence intensity of CXCR4 in small and large sizes of MKs by flow cytometry. Scale bars, 20µm. Data represent mean ± s.e.m in (<bold>B, D, E, H</bold>) or mean ±first and third quartiles in (<bold>G</bold>). Two-sample KS test was performed to assess statistical significance in (<bold>G</bold>). Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance in (<bold>B, D, E, H</bold>). * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig1-figsupp6-v2.tif"/></fig></fig-group><p>Enriched signature genes by Gene Ontology exhibited that MK1 and MK2 highly expressed nuclear division, DNA replication and repair genes for endomitosis (<xref ref-type="fig" rid="fig1">Figure 1C,D</xref>). MK3 enriched blood coagulation and thrombosis genes for platelet generation (<xref ref-type="fig" rid="fig1">Figure 1C,D</xref>). No signature pathways were enriched in MK4. MK5 enriched cell migration and immune response genes (<xref ref-type="fig" rid="fig1">Figure 1C,D</xref>; <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A-E</xref>), cytokine, chemokine (<xref ref-type="fig" rid="fig1">Figure 1E,F</xref>; <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4F</xref>), and genes involved in immune cell interaction (<xref ref-type="fig" rid="fig1">Figure 1G</xref>, <xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5A</xref>). MK5 also expressed signature genes in recently reported inflammatory-related MKs (<italic>Cd53</italic>, <italic>Lsp1</italic>, <italic>Anxa1</italic>, <italic>Spi</italic>) (<xref ref-type="bibr" rid="bib68">Sun et al., 2021</xref>) and immune MKs (<italic>Ccl3</italic>, <italic>Cd52</italic>, <italic>Selplg</italic>, <italic>Sell</italic>, <italic>Adam8</italic>) (<xref ref-type="bibr" rid="bib45">Liu et al., 2021</xref>; <xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B</xref>). We also noticed that MK5 highly expressed <italic>Cxcr4</italic> than other MK subpopulations (<xref ref-type="fig" rid="fig1">Figure 1H,I</xref>), although most MKs express CXCR4 (<xref ref-type="bibr" rid="bib30">Hamada et al., 1998</xref>; <xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6A</xref>). To confirm this, we found that CXCR4<sup>high</sup> MKs expressed MK markers (<xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6B</xref>), were mainly polyploid cells (<xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6C</xref>), and had platelet generation ability (<xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6D</xref>), although they have relatively low polyploidy (<xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6E</xref>) and smaller cell size (<xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6F-H</xref>). CXCR4<sup>high</sup> MKs generated platelets in lower efficiencies compared to CXCR4<sup>low</sup> MKs (<xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6D</xref>), suggesting CXCR4<sup>high</sup> MKs might be specialized for immune functions. Overall, using scRNA-seq, we identified an MK subpopulation that exhibited both MK-specific and immune transcriptional characteristics.</p></sec><sec id="s2-2"><title>CXCR4<sup>high</sup> MKs enhance myeloid cell mobility and bacterial phagocytosis</title><p>As MK5 enriched genes involved in myeloid cell activation (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4E</xref>) and myeloid cell interactions (<xref ref-type="fig" rid="fig1">Figure 1G</xref>, <xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5A</xref>), we further explored the role of CXCR4<sup>high</sup> MKs, which enriched MK5, in regulating myeloid immune cells, in regulating the innate immunity function of myeloid cells against pathogens. We challenged mice with <italic>Listeria</italic> (<italic>L</italic>.) <italic>monocytogenes</italic>, a Gram-positive facultative intracellular bacterium (<xref ref-type="bibr" rid="bib6">Bishop and Hinrichs, 1987</xref>; <xref ref-type="bibr" rid="bib23">Edelson and Unanue, 2000</xref>), which induce myelopoiesis (<xref ref-type="bibr" rid="bib22">Eash et al., 2009</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A, B</xref>). Interestingly, we noticed that CXCR4<sup>high</sup> MKs were more dramatically associated with myeloid cells in the bone marrow of mice 3 days after <italic>L. monocytogenes</italic> infection, which was a significant increase than the association between myeloid cells and CXCR4<sup>low</sup> MKs or the association between randomly placed myeloid cells and CXCR4<sup>high</sup> MKs (<xref ref-type="fig" rid="fig2">Figure 2A,B</xref>). The myeloid cell-CXCR4<sup>high</sup> MK association (mean distance 15.36 μm) was significantly closer than the myeloid cell-CXCR4<sup>low</sup> MKs association (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; mean distance 25.62 μm, p=7.0 × 10<sup>–4</sup> by KS test), and the association between randomly placed myeloid cells and CXCR4<sup>high</sup> MKs [35.37 μm, <italic>p</italic> (μ&lt;15.36)=1.8 × 10<sup>–10</sup>] in the bone marrow of mice 3 days after <italic>L. monocytogenes</italic> infection. Whereas the observed mean distance of myeloid cells to CXCR4<sup>low</sup> MKs (25.62 μm) is not different from random simulations [27.76 μm, <italic>p</italic> (μ&lt;25.62)=0.14] (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). This suggested that the increased association between myeloid cell-CXCR4<sup>high</sup> MK may not be due to the infection-induced expansion of myeloid cells. Furthermore, we did not observe a significant association between myeloid cells and MKs during homeostasis (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C,D</xref>). We also noticed that bone marrow myeloid cells were preferably adjacent to the CXCR4<sup>high</sup> MK-blood vessel intersection in mice 3 days after <italic>L. monocytogenes</italic> infection (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E,F</xref>). These observations indicated that CXCR4<sup>high</sup> MKs might regulate myeloid cells upon bacterial infection.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>CXCR4<sup>high</sup> MKs enhance myeloid cell mobility and bacteria phagocytosis.</title><p>(<bold>A</bold>) Distribution of myeloid cells to CXCR4<sup>low</sup> or CXCR4<sup>high</sup> MKs 3 days after <italic>L. monocytogenes</italic> infection. Representative images of MKs (blue), CXCR4 (red), and myeloid cells (green) in mouse bone marrow. Yellow arrows indicate CXCR4<sup>high</sup> MKs and white arrowheads indicate CXCR4<sup>low</sup> MKs. (<bold>B–C</bold>) Distance (<bold>B</bold>) and mean distance (<bold>C</bold>) of actual or randomly positioned myeloid cells to the closest CXCR4<sup>low</sup> and CXR4<sup>high</sup> MKs 3 days after <italic>L. monocytogenes</italic> infection. (<bold>D</bold>) Numbers of transmigrated myeloid cells normalized to Ctrl (without MKs in the lower chambers) as indicated by transwell assays. Mon, monocytes; MΦ, macrophages; DC, dendritic cells; Neu, neutrophils. (<bold>E–F</bold>) Representative images (<bold>E</bold>) and quantification (<bold>F</bold>) of neutrophil phagocytosis capacity with or without MK co-culture as indicated. CD11b, red; <italic>E. coli</italic>, green; DAPI, blue. Ctrl, neutrophil without MK co-culture. (<bold>G–H</bold>) Representative images (<bold>G</bold>) and quantification (<bold>H</bold>) of macrophage phagocytosis capacity with or without MK co-culture as indicated. F4/80, red; <italic>E. coli</italic>, green; DAPI, blue. Ctrl, macrophage without MK co-culture. (<bold>I</bold>) Spearman correlation analysis between expression profiles of <italic>Cxcr4</italic> and feature genes in MK subpopulations. (<bold>J</bold>) Quantification of TNFα<sup>+</sup> and IL-6<sup>+</sup> cells in CXCR4<sup>low</sup> MKs and CXCR4<sup>high</sup> MKs from control mice or mice 3 days after <italic>L. monocytogenes</italic> infection. (<bold>K–L</bold>) Quantification of neutrophil (<bold>K</bold>) and macrophage (<bold>L</bold>) phagocytosis with or without CXCR4<sup>high</sup> MK co-culture in the absence or presence of anti-TNFα or anti-IL-6 neutralizing antibodies. (<bold>M–N</bold>) Quantification of the phagocytosis abilities by neutrophils (<bold>M</bold>) and macrophages (<bold>N</bold>) with or without CXCR4<sup>low</sup> MK or CXCR4<sup>high</sup> MK co-culture in the absence or presence of anti-TNFα or anti-IL-6 neutralizing antibodies by flow cytometry. Ctrl, neutrophils (<bold>M</bold>) or macrophages (<bold>N</bold>) without MKs co-culture. Scale bars, 20 μm (<bold>A, E, G</bold>). Data represent mean ± s.e.m (<bold>D</bold>) and boxplots show medians, first and third quartiles (<bold>F, H, K–L</bold>). Repeated-measures one-way ANOVA followed by Dunnett’s test for multiple comparisons in (<bold>D, M, N</bold>), ǂ p&lt;0.05, ǂǂ p&lt;0.01, n.s., not significant. A two-sample KS test was performed to assess statistically significant (<bold>C, F, H, K, L</bold>), n.s., not significant. Paired Student’s <italic>t</italic>-test was performed to assess statistical significance (<bold>J</bold>), # p&lt;0.05, ## p&lt;0.01, n.s., not significant.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Distance of actual myeloid cells to the closest CXCR4<sup>low</sup> and CXR4<sup>high</sup> MKs 3 days after <italic>L</italic>. <italic>monocytogenes</italic> infection.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78662-fig2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Distance of randomly positioned myeloid cells to the closest CXCR4<sup>low</sup> and CXR4<sup>high</sup> MKs 3 days after <italic>L</italic>. <italic>monocytogenes</italic> infection.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78662-fig2-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Mean distance of randomly positioned myeloid cells to the closest CXCR4<sup>low</sup> and CXR4<sup>high</sup> MKs 3 days after <italic>L</italic>. <italic>monocytogenes</italic> infection from 500 times simulations.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78662-fig2-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>L. monocytogenes</italic> promote myelopoiesis and the association of myeloid cells and the CXCR4<sup>high</sup> MK-blood vessel intersection.</title><p>(<bold>A–B</bold>) Representative immunofluorescent staining image (<bold>A</bold>) and statistical analysis (<bold>B</bold>) showing association of MKs (blue) and myeloid cells (green) in the bone marrow of control mice and mice 3 days after <italic>L. monocytogenes</italic> infection (n=30 control and infected MKs). CD41, blue; CD11b, green. (<bold>C–D</bold>) Distance (<bold>C</bold>) and mean distance (<bold>D</bold>) of actual or randomly positioned myeloid cells to the closest CXCR4<sup>low</sup> Mks and CXR4<sup>high</sup> MKs from mice without infection. (<bold>E–F</bold>) Representative images of MKs (blue), CXCR4 (red), vascular endothelial cells (green) and myeloid cells (white) (<bold>E</bold>), and statistical analysis (<bold>F</bold>) in bone marrow showing the distribution of myeloid cells to CXCR4<sup>low</sup> or CXCR4<sup>high</sup> MKs and vascular cells 3 days after <italic>L. monocytogenes</italic> infection. CD41, blue; CXCR4, red; EMCN, green; CD11b, white. Yellow arrows indicate CXCR4<sup>high</sup> MKs and white arrowheads indicate CXCR4<sup>low</sup> MKs (left) and two-dimensional probability distribution of distances from myeloid cells to CXCR4<sup>low</sup> or CXCR4<sup>high</sup> MKs and vascular cells (n=104 CD11b<sup>+</sup> cells; p=0.04 by 2D KS test). Scale bars, 20µm. Boxplots show medians, first and third quartiles in (<bold>B</bold>). Two-sample KS test was performed to assess statistical significance in (<bold>B, D</bold>). Two-dimensional-two-sample KS test was performed to assess statistical significance in (<bold>F</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>CXCR4<sup>high</sup> MKs promote myeloid cell phagocytosis and produce TNFα and IL-6.</title><p>(<bold>A–B</bold>) Quantification of phagocytosis abilities in neutrophils (<bold>A</bold>) and macrophages (<bold>B</bold>) without or with CXCR4<sup>low</sup> MKs or CXCR4<sup>high</sup> MKs as indicated. (<bold>C–E</bold>) TNFα and IL-6 protein levels in CXCR4<sup>low</sup> and CXCR4<sup>high</sup> MKs were shown by immunofluorescent staining (<bold>C–D</bold>) using sorted MKs, compared to their levels in sorted macrophages upon <italic>L. monocytogenes</italic> infection (<bold>E</bold>).Scale bars, 5μm. Data represent mean ± s.e.m in (<bold>A, B</bold>) and boxplots show medians, first and third quartiles in (<bold>C–E</bold>). Repeated-measures one-way ANOVA followed by Dunnett’s test for multiple comparisons in (<bold>A, B</bold>), ǂ p&lt;0.05, ǂǂ p&lt;0.01. Two-sample KS test was performed to assess statistical significance in (<bold>C–E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig2-figsupp2-v2.tif"/></fig></fig-group><p>To explore how CXCR4<sup>high</sup> MKs regulate myeloid cells, we interestingly found that CXCR4<sup>high</sup> MKs, but not CXCR4<sup>low</sup> MKs, effectively promoted myeloid cell mobilization in our transwell assays (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Furthermore, we asked whether CXCR4<sup>high</sup> MKs regulate myeloid cell function against pathogens. To this aim, we incubated purified CXCR4<sup>low</sup> MKs and CXCR4<sup>high</sup> MKs with neutrophils or macrophages for bacterial phagocytosis analysis. We found that CXCR4<sup>high</sup> MKs, but not CXCR4<sup>low</sup> MKs, efficiently enhanced the bacterial phagocytosis of neutrophils and macrophages (<xref ref-type="fig" rid="fig2">Figure 2E–H</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A,B</xref>).</p><p>Our scRNA-seq also exhibited that the high expression of <italic>Cxcr4</italic> was positively correlated with immune cell-stimulating cytokines, such as <italic>Ccl6</italic>, <italic>Tnf</italic>, and <italic>Il6</italic> (<xref ref-type="bibr" rid="bib44">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib60">Rothe et al., 1993</xref>; <xref ref-type="bibr" rid="bib63">Shapouri-Moghaddam et al., 2018</xref>) in MKs (<xref ref-type="fig" rid="fig2">Figure 2I</xref>). In line with this, CXCR4<sup>high</sup> MKs had higher TNFα and IL-6 protein levels than CXCR4<sup>low</sup> MKs (<xref ref-type="fig" rid="fig2">Figure 2J</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C,D</xref>). The TNFα and IL-6 levels in CXCR4<sup>high</sup> MKs were comparable to macrophages from mice 3 days after <italic>L. monocytogenes</italic> infection (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2E</xref>), which are known as the primary cellular source of TNFα and IL-6 upon infection (<xref ref-type="bibr" rid="bib63">Shapouri-Moghaddam et al., 2018</xref>). These observations suggested that CXCR4<sup>high</sup> MKs might stimulate myeloid cell phagocytosis by producing TNFα and IL-6. Indeed, anti-TNFα and anti-IL-6 blocking antibodies compromised the role of CXCR4<sup>high</sup> MKs in stimulating bacterial phagocytosis of neutrophils and macrophages (<xref ref-type="fig" rid="fig2">Figure 2K–N</xref>).</p></sec><sec id="s2-3"><title>CXCR4<sup>high</sup> MKs stimulate host-defense immunity against bacterial pathogens</title><p>To explore the in vivo role of MKs upon <italic>L. monocytogenes</italic> infection in mice, we employed <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-iDTR</sup></italic> mice, in which MKs were rendered sensitive to diphtheria toxin (DT) (<xref ref-type="bibr" rid="bib84">Zhao et al., 2014</xref>; <xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). MK ablation increased the number of hematopoietic stem and progenitor cells and myelopoiesis in the bone marrow upon infection (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A-D</xref>). Notably, MK ablation dramatically increased the bacterial burdens in the liver and spleen 3 days after <italic>L. monocytogenes</italic> infection (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). We also found that MK ablation reduced the number of myeloid cells, including monocytes, macrophages, dendritic cells (DCs), and neutrophils, in the liver and spleen (<xref ref-type="fig" rid="fig3">Figure 3D,E</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E,F</xref>), suggesting the role of MKs in promoting myeloid cells against pathogens. We further investigated whether MKs regulate adaptative immunity against pathogen infection. Interestingly, we noticed that CXCR4<sup>high</sup> MKs were able to phagocytose bacteria and presented the ovalbumin (OVA) antigens on their surface via MHC-I (<xref ref-type="fig" rid="fig3">Figure 3F,G</xref>). Furthermore, OVA antigens presented by CXCR4<sup>high</sup> MKs activated OT-I CD8<sup>+</sup> T cells (<xref ref-type="fig" rid="fig3">Figure 3H</xref>) and B3Z T cells (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>), a T cell hybridoma which expresses TCR that specifically recognizes OVA (<xref ref-type="bibr" rid="bib40">Karttunen et al., 1992</xref>). We challenged <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-iDTR</sup></italic> mice with OVA-expressing recombinant microbe (<italic>L. monocytogenes</italic>-OVA). Seven days after <italic>L. monocytogenes</italic>-OVA infection, splenocytes from control or MK ablated mice were re-stimulated with OVA peptide in vitro to assess OVA-specific T cell activation (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). Notably, MK ablation dramatically reduced the number of CD4<sup>+</sup> IFNγ<sup>+</sup> Th1, CD4<sup>+</sup> IL4<sup>+</sup> Th2, and CD8<sup>+</sup> cytotoxic T lymphocytes but did not impact the total number of CD4<sup>+</sup> T cells and CD8<sup>+</sup> T cells (<xref ref-type="fig" rid="fig3">Figure 3J</xref>). These observations demonstrated that MKs regulate host-defense immunity against <italic>L. monocytogenes</italic> infection. To explore whether CXCR4<sup>high</sup> MKs contribute to the immune response against bacterial pathogens, we infused the purified CXCR4<sup>high</sup> MKs and CXCR4<sup>low</sup> MKs into MK ablation mice during <italic>L. monocytogenes</italic> infection (<xref ref-type="fig" rid="fig3">Figure 3K</xref>). Notably, we found that the infusion with CXCR4<sup>high</sup> MKs, but not CXCR4<sup>low</sup> MKs, partially rescued the bacterial clearance defect in MK ablation mice (<xref ref-type="fig" rid="fig3">Figure 3L</xref>). This is potentially due to the reduced platelets known for regulating immune responses (<xref ref-type="bibr" rid="bib62">Semple et al., 2011</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>CXCR4<sup>high</sup> MKs stimulate host-defense immunity against bacterial pathogens.</title><p>(<bold>A</bold>) Schema for diphtheria toxin (DT) and <italic>L. monocytogenes</italic> administration used for the experiments shown in (<bold>B–E</bold>). (<bold>B</bold>) Representative images of MKs (blue, indicated by arrows) and vascular endothelial cells (green) in the bone marrow of mice after four daily DT treatments. (<bold>C</bold>) Bacterial burdens in the liver and spleen of <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-iDTR</sup></italic> mice 3 days after <italic>L. monocytogenes</italic> (<italic>L.m</italic>.) infection with four-time DT injections. (<bold>D–E</bold>) Myeloid cells in the liver (<bold>D</bold>) and spleen (<bold>E</bold>) of <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-iDTR</sup></italic> mice 3 days after <italic>L. monocytogenes</italic> (<italic>L.m</italic>.) infection with four-time DT injections. (<bold>F</bold>) Quantification of bacterial phagocytosis capacities of neutrophils, CXCR4<sup>low</sup> MKs and CXCR4<sup>high</sup> MKs. (<bold>G</bold>) Quantification of MHCI-OVA levels on CXCR4<sup>low</sup> MKs, CXCR4<sup>high</sup> MKs and bone-marrow-derived dendritic cells (DCs) upon a pulse of 24 hr with or without OVA. (<bold>H</bold>) Quantification of activated OT-I CD8<sup>+</sup> T cells after co-culture with bone-marrow-derived DCs, OVA-pulsed bone-marrow-derived DCs, CXCR4<sup>low</sup> MKs, or CXCR4<sup>high</sup> MKs. (<bold>I</bold>) Schema for antigen-specific T cell activation assay shown in (<bold>J</bold>). (<bold>J</bold>) Splenocytes from control or MK ablated mice 7 days after <italic>L. monocytogenes</italic>-OVA<sub>257-264</sub> infection and seven DT injections were stimulated with OVA peptide in vitro for 4 hr, and antigen-specific activated T cells were quantified (n=4 mice). <italic>L.m</italic>.-OVA, <italic>L. monocytogenes</italic>-OVA<sub>257-264</sub>. (<bold>K</bold>) Schema for DT, <italic>L. monocytogenes</italic> administration, MK transfusing and bacterial burden determination shown in (<bold>L</bold>). (<bold>L</bold>) Bacterial burdens in the liver and spleen of <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-iDTR</sup></italic> mice without or with CXCR4<sup>low</sup> or CXCR4<sup>high</sup> MK transfused. Scale bars, 20μm. Data represent mean ± s.e.m. Repeated-measures one-way ANOVA followed by Dunnett’s test for multiple comparisons in (<bold>F</bold>), ǂǂǂ p&lt;0.001. Paired Student’s <italic>t</italic>-test was performed to assess statistical significance (<bold>G</bold>), # p&lt;0.05, n.s., not significant. Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance except (<bold>F</bold>), * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001, n.s., not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>MK ablation influenced HSC and myeloid cell numbers.</title><p>(<bold>A</bold>) Schema for diphtheria toxin (DT) and <italic>L. monocytogenes</italic> administration used for the experiments shown in (<bold>B–D</bold>). (<bold>B</bold>) Number of bone marrow hematopoietic stem and progenitor cells in <italic>Pf4<sup>Cre+</sup>; Rosa26<sup>fs-iDTR</sup></italic><sup>+/-</sup> mice compared to <italic>Pf4<sup>Cre</sup></italic><sup>-</sup>; <italic>Rosa26<sup>fs-iDTR</sup></italic><sup>+/-</sup> mice after <italic>L. monocytogenes</italic> infection and DT injection. (<bold>C–D</bold>) Gating strategies (<bold>C</bold>) and numbers (<bold>D</bold>) of myeloid cells in the bone marrow of <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-iDTR</sup></italic><sup>+/-</sup> mice after <italic>L. monocytogenes</italic> infection and DT injection. (<bold>D–E</bold>) Gating strategies of myeloid cells in the liver (<bold>D</bold>) and spleen (<bold>E</bold>) of <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-iDTR</sup></italic><sup>+/-</sup> mice at 3 days after <italic>L. monocytogenes</italic> infection. Neu, neutrophil; MF, macrophage; Mono, monocyte; DC, dendritic cell. Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance. * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>CXCR4<sup>high</sup> MKs induced B3Z T cell activation.</title><p>The LacZ activity in B3Z T cells with or without co-culture as indicated. Ctrl indicates B3Z cells without MKs co-culture; bone-marrow-derived DCs, CXCR4<sup>low</sup> MKs and CXCR4<sup>high</sup> MKs were pulsed with OVA for 24 hr. Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance, * p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig3-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Bacterial infection stimulates the migration of CXCR4<sup>high</sup> MKs</title><p>High <italic>Cxcr4</italic> expression indicated that CXCR4<sup>high</sup> MKs might migrate between the bone marrow microenvironment and circulation in response to infection (<xref ref-type="bibr" rid="bib69">Suraneni et al., 2018</xref>). In line with this, our spatial distribution analysis showed that ~80% of MKs directly contacted blood vessels 3 days after <italic>L. monocytogenes</italic> infection, which was much higher than in control mice (~40%) (<xref ref-type="fig" rid="fig4">Figure 4A,B</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Furthermore, more CXCR4<sup>high</sup> MKs, with small cell sizes (<xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6F-H</xref>), were tightly associated with blood vessels and trapped in the sinusoid than CXCR4<sup>low</sup> MKs 3 days after <italic>L. monocytogenes</italic> infection (<xref ref-type="fig" rid="fig4">Figure 4C,D</xref>). However, <italic>L. monocytogenes</italic> infection did not influence the association between MKs and HSCs (<xref ref-type="fig" rid="fig4">Figure 4A,E</xref>), albeit the critical role of perivascular MKs in maintaining HSC quiescence (<xref ref-type="bibr" rid="bib8">Bruns et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Itkin et al., 2016</xref>; <xref ref-type="bibr" rid="bib84">Zhao et al., 2014</xref>) and the dramatic HSC activation upon infection (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Bacterial infection stimulates the migration of CXCR4<sup>high</sup> MKs.</title><p>(<bold>A</bold>) Representative image of CD41 (blue), CD150 (red), EMCN (green), and lineage cells (white) in bone marrow from control mice or mice at 3 days after <italic>L. monocytogenes</italic> infection. d<sub>HSC</sub> and d<sub>EC</sub> indicate the distance between the MK (blue, marked with an asterisk) and the closest HSC (red), endothelial cell (green), respectively. Yellow boxes indicate the locations of the magnified images. Arrowheads indicate HSCs. EMCN, endomucin; EC, endothelial cell. (<bold>B</bold>) Comparison of the distance between MKs to Ecs (n=119 control and 103 infected MKs) in the bone marrow of control mice or mice at 3 days after <italic>L. monocytogenes</italic> infection. (<bold>C</bold>) Comparison of the distance between CXCR4<sup>low</sup> or CXCR4<sup>high</sup> MKs and endothelial cells (Ecs) in the bone marrow of mice 3 days after <italic>L. monocytogenes</italic> infection (n=68 CXCR4<sup>low</sup> and 78 CXCR4<sup>high</sup> MKs). CD41 (blue), CXCR4 (red), and EMCN (green). Yellow arrows indicate CXCR4<sup>high</sup> MKs, while white arrowheads indicate CXCR4<sup>low</sup> MKs. (<bold>D</bold>) Representative immunofluorescent staining images (left) and quantification (right) of CXCR4 (red) labeled MKs (blue) egressed into sinusoids (green) upon infection (n=46 CXCR4<sup>low</sup> MKs and 69 CXCR4<sup>high</sup> MKs in 4 biological replicates). Yellow arrows indicate CXCR4<sup>high</sup> MKs. (<bold>E</bold>) Comparison of the distance between HSCs to MKs (n=96 control and 127 infected HSCs, p=0.21 by two-sample KS test) in the bone marrow of control mice or mice at 3 days after <italic>L. monocytogenes</italic> infection. (<bold>F</bold>) Visualization of MK migration (red, arrowhead) into sinusoids (green) by live imaging in the bone marrow of <italic>Pf4<sup>Cre</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs-tdTomato</sup></italic><sup>+/-</sup> mice 24 hr after <italic>L. monocytogenes</italic> infection (Movie S1). ‘S’ indicates sinusoid and dashed lines demarcate the border of sinusoids. (<bold>G</bold>) Quantification of CXCR4<sup>high</sup> MKs in bone marrow, peripheral blood, liver, spleen, and lung of control mice and mice 3 days after <italic>L. monocytogenes</italic> infection. (<bold>H</bold>) Quantification of CXCR4 levels on CXCR4<sup>low</sup> MKs treated with IFN-γ, LPS or <italic>L. monocytogenes</italic> for 4 hr compared to CXCR4<sup>high</sup> MKs. (<bold>I</bold>) Quantification of tdTomato<sup>+</sup> CXCR4<sup>high</sup> MKs in the liver and spleen from control mice or mice 3 days after <italic>L. monocytogenes</italic> infection by flow cytometry. (<bold>J</bold>) Schema of mtdTomato<sup>+</sup> bone marrow (from <italic>R26R<sup>mTmG</sup></italic> mice) cell perfusion in control and <italic>L. monocytogenes</italic> infected recipients. (<bold>K</bold>) The percentage of CXCR4<sup>high</sup> mtdTomato<sup>+</sup> MKs and CXCR4<sup>low</sup> mtdTomato<sup>+</sup> MKs in bone marrow, liver, and spleen of control or infected recipients were analyzed 2 days after mtdTomato<sup>+</sup> bone marrow cells were perfused. (<bold>L</bold>) Radar chart showing transcriptomic similarities of bone marrow MK subpopulations with reported BM and lung MK datasets (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>). (<bold>M</bold>) Schema for transfer experiments using tdTomato<sup>+</sup> MKs from <italic>Pf4<sup>Cre</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs-tdTomato</sup></italic><sup>+/-</sup> mice into control recipients or recipients 1 day following <italic>L. monocytogenes</italic> infection. (<bold>N–O</bold>) Representative images (<bold>N</bold>) and quantification by flow cytometry (<bold>O</bold>) of tdTomato<sup>+</sup> MKs in the lung of control or infected recipients 2 days after cell perfusion (n=3 mice). Arrows indicate tdTomato<sup>+</sup> MKs in the lung. Scale bars without indicated, 20 μm. Data represent mean ± s.e.m. A two-sample KS test was performed to assess statistical significance in (<bold>E</bold>). Repeated-measures one-way ANOVA followed by Dunnett’s test for multiple comparisons in (<bold>H</bold>), ǂǂ p&lt;0.01, ǂǂǂ p&lt;0.001. Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance except (<bold>E, H</bold>), * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001, n.s., not significant.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Distance of HSCs to MKs in the bone marrow from control mice or mice 3 days after <italic>L</italic>. <italic>monocytogenes</italic> infection.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78662-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>The effects of association of MKs and blood vessels, HSC activation, and MK numbers in bone marrow upon bacterial infection.</title><p>(<bold>A</bold>) Bone marrow MKs (blue) and sinusoids (green) in control mice and mice 3 days after <italic>L. monocytogenes</italic> infection. CD41, blue; EMCN, green. Yellow arrows indicate MKs egressed into sinusoids. ‘S’ indicates sinusoid and dashed lines demarcate the border of sinusoids. (<bold>B</bold>) HSC and progenitor cell number in the bone marrow of control mice and mice 3 days after <italic>L. monocytogenes</italic> infection. LT, long term; ST, short term; MPP, multipotential progenitor. (<bold>C–D</bold>) MK numbers (<bold>C</bold>) and CXCR4<sup>low</sup> MK frequency (<bold>D</bold>) in the bone marrow of control mice and mice 3 days after <italic>L. monocytogenes</italic> infection (n=8 mice). (<bold>E–F</bold>) Frequency of BrdU<sup>+</sup> (<bold>E</bold>) and Annexin V<sup>+</sup> (<bold>F</bold>) cells in CXCR4<sup>high</sup> MKs from bone marrow of control mice or mice 3 days after <italic>L. monocytogenes</italic> infection (n=5 mice). Scale bars, 20µm. Data represent mean ± s.e.m. Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance. * p&lt;0.05, n.s., not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>scRNA-seq of MKs from mice upon bacterial infection.</title><p>(<bold>A</bold>) Schematic depicting the strategy of scRNA-seq using bone marrow MKs from mice 3 days after <italic>L. monocytogenes</italic> infection. (<bold>B</bold>) Violin plots showing the number of unique genes (gene number) before and after removing doublets, number of total unique molecular identifiers (UMI counts) and percentage of mitochondrial transcripts in single cells after removing doublets. Scatter plot showing the correlation between UMI counts and gene numbers. corr indicates Pearson correlation coefficient. (<bold>C</bold>) UMAP of the combined 5368 cells from control bone marrow and 4276 cells from <italic>L. monocytogenes</italic> infection bone marrow, colored by cell types. Neu, neutrophil; MP, myeloid progenitor; Mon, monocytes; B, B cells; T, T cells. (<bold>D</bold>) UMAP of the combined 1712 control MKs and 1560 infection MKs in the bone marrow, colored by clusters. (<bold>E</bold>) Fraction of each MK subpopulation from control MKs or <italic>L. monocytogenes</italic> infection MKs. (<bold>F</bold>) Violin plot showing <italic>Cxcr4</italic> expression in each MK subpopulation of control and infection MKs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>CXCL12 expression upon bacterial infection.</title><p>(<bold>A–H</bold>) Relative expression of <italic>Cxcl12</italic> (<bold>A–D</bold>) and frequency of CXCL12<sup>DsRed</sup> cells (<bold>E–H</bold>) in the bone marrow (<bold>A</bold>), lung (<bold>B</bold>), liver (<bold>C</bold>), and spleen (<bold>D</bold>) from control mice and mice 3 days after <italic>L. monocytogenes</italic> infection by RT-qPCR (<bold>A–D</bold>) and flow cytometry (<bold>E–H</bold>), respectively. Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance. * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig4-figsupp3-v2.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Cell cycle and apoptosis of CXCR4<sup>high</sup> MKs, and CXCR4<sup>low</sup> MK numbers in different organs upon bacterial infection.</title><p>(<bold>A–B</bold>) Fraction of BrdU<sup>+</sup> and Annexin V<sup>+</sup> MKs in CXCR4<sup>high</sup> MKs in the liver (<bold>A</bold>) and spleen (<bold>B</bold>) from control mice or mice 3 days after <italic>L. monocytogenes</italic> infection. (<bold>C</bold>) Quantification of CXCR4<sup>low</sup> MKs in peripheral blood, liver, spleen, and lung of control mice and mice at 3 days after <italic>L. monocytogenes</italic> infection. (<bold>D</bold>) Quantification of CXCR4 levels on CXCR4<sup>high</sup> MKs and CXCR4<sup>low</sup> MKs treated with LPS or IFN-γ for 18 or 24 hr. (<bold>E–F</bold>) Representative images and quantification of mGFP<sup>+</sup> MKs (green) in the liver (<bold>E</bold>) and spleen (<bold>F</bold>) from control mice or mice 3 days after <italic>L. monocytogenes</italic> infection (n=4 and 7 mice, respectively). (<bold>G–H</bold>) Gating strategies for CXCR4<sup>high</sup> MKs in the liver (<bold>G</bold>) and spleen (<bold>H</bold>). (<bold>I</bold>) Quantification of tdTomato<sup>+</sup>CXCR4<sup>low</sup> MKs in the liver and spleen from control mice or mice 3 days after <italic>L. monocytogenes</italic> infection by flow cytometry. Scale bars, 20μm. Data represent mean ± s.e.m. Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance except (<bold>D</bold>). * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001, n.s., not significant. Repeated-measures one-way ANOVA followed by Dunnett’s test for multiple comparisons in (<bold>D</bold>), ǂǂ p&lt;0.01, ǂǂǂ p&lt;0.01.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig4-figsupp4-v2.tif"/></fig><fig id="fig4s5" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 5.</label><caption><title>Comparison of immune gene expression in MK5 and lung MKs from control mice or mice upon bacterial infection.</title><p>(<bold>A</bold>) Gene set variation analysis (GSVA) of each MK subpopulation under control or <italic>L. monocytogenes</italic> infection, colored by row-scaled GSVA enrichment scores. (<bold>B</bold>) Antigen processing and presentation score of control MK5, infection MK5, and bone marrow and lung MKs from <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>. (<bold>C</bold>) Heatmap showing the row-scaled antigen processing and presentation gene expression of control and infection MK5 cells, comparing with bone marrow MK and lung MK from <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>. Data represent mean ±first and third quartiles in (<bold>B</bold>). Two-sample KS test was performed to assess statistical significance in (<bold>B</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig4-figsupp5-v2.tif"/></fig><fig id="fig4s6" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 6.</label><caption><title>Intravascular and extravascular tdTomato<sup>+</sup> MKs in the lung after MK perfusion.</title><p>(<bold>A</bold>) Schema for transfer experiments using tdTomato<sup>+</sup> MKs from <italic>Pf4<sup>Cre</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs</sup></italic><sup>-<italic>tdTomato</italic>+/-</sup> mice into recipients 1 day following <italic>L. monocytogenes</italic> infection. (<bold>B</bold>) Transfused MKs (red) and sinusoids (green) in the lung of mice after <italic>L. monocytogenes</italic> infection as indicated in <xref ref-type="fig" rid="fig4">Figure 4M</xref>. DAPI, blue; EMCN, green; tdTomato, red. (<bold>C</bold>) Quantification of transfused intravascular and extravascular MKs in the lung. Scale bar, 20μm. Data represent mean ± s.e.m. Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance. *** p&lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig4-figsupp6-v2.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-78662-fig4-video1.mp4" id="fig4video1"><label>Figure 4—video 1.</label><caption><title>MK migration traced by ex vivo live imaging.</title><p>MK (red, arrowhead) migrating into the bone marrow sinusoids (green, labeled by Dextran-FITC) by live imaging in the bone marrow of <italic>Pf4<sup>Cre</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs</sup></italic><sup>-<italic>tdTomato</italic>+/-</sup>mice 24 hr after <italic>L. monocytogenes</italic> infection. Scale bar, 10μm.</p></caption></media></fig-group><p>To further explore the dynamic migration of MKs upon pathogen infection, we adapted an ex vivo real-time imaging method to trace MK migration in the bone marrow (<xref ref-type="bibr" rid="bib77">Xie et al., 2009</xref>). Using <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice and ex vivo live imaging approach, we observed that small tdTomato<sup>+</sup> MKs rapidly migrated into sinusoids without rupture or platelet release upon infection (<xref ref-type="fig" rid="fig4">Figure 4F</xref>, <xref ref-type="video" rid="fig4video1">Figure 4—video 1</xref>). In contrast, MKs with large sizes showed much slower migration (<xref ref-type="video" rid="fig4video1">Figure 4—video 1</xref>). Additionally, CXCR4<sup>high</sup> MKs were decreased in the bone marrow 3 days after <italic>L. monocytogenes</italic> infection but with a similar proliferation and apoptosis rate compared to CXCR4<sup>low</sup> MKs (<xref ref-type="fig" rid="fig4">Figure 4G</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C-F</xref>), indicating CXCR4<sup>high</sup> MKs might migrate out of bone marrow. Consistent with this, the frequency of MK5, which enriched CXCR4<sup>high</sup> MKs, decreased in bone marrow after <italic>L. monocytogenes</italic> infection in our single-cell atlas (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Furthermore, we found that <italic>L. monocytogenes</italic> infection decreased the expression of CXCL12, the ligand of CXCR4 (<xref ref-type="bibr" rid="bib67">Sugiyama et al., 2006</xref>), in bone marrow but increased CXCL12 expression in the lung, liver, and spleen (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>), suggesting that the distinguished CXCL12 levels between tissues might drive the migration of CXCR4<sup>high</sup> MKs between tissues. In line with this, CXCR4<sup>high</sup> MKs were increased in the peripheral blood and organs, including the liver, spleen, and lung 3 days after <italic>L. monocytogenes</italic> infection without an alternation of cell cycle and apoptosis, whereas CXCR4<sup>low</sup> MKs did not differ except for a slight increase in the liver (<xref ref-type="fig" rid="fig4">Figure 4G</xref>; <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4A-C</xref>). Moreover, inflammatory stresses, such as IFNγ and Lipopolysaccharides (LPS), or <italic>L. monocytogenes</italic> treatment did not increase CXCR4 expression in CXCR4<sup>low</sup> MKs (<xref ref-type="fig" rid="fig4">Figure 4H</xref>; <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4D</xref>).</p><p>To further explore how MKs migrate between organs during bacterial infection in vivo, we employed <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-tdTomato</sup></italic>, <italic>and Pf4<sup>Cre</sup>; cell membrane-localized tdTomato cell membrane-localized EGFP</italic> (<italic>Rosa26<sup>fs-mTmG</sup></italic>) mice in which Tomato or cell membrane-localized EGFP (mGFP) were exclusively expressed in MK lineage (<xref ref-type="bibr" rid="bib71">Tiedt et al., 2007</xref>). mGFP expressing MKs or Tomato expressing CXCR4<sup>high</sup> MKs were increased in the liver and spleen 3 days after <italic>L. monocytogenes</italic> infection (<xref ref-type="fig" rid="fig4">Figure 4I</xref>; <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4E-H</xref>), whereas Tomato expressing CXCR4<sup>low</sup> MKs did not change (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4I</xref>). To further confirm the tissue infiltration of MKs upon infection, we intravenously injected membrane-localized tdTomato (mTomato) expressing bone marrow cells from <italic>Rosa26R<sup>fs-mTmG</sup></italic> mice into control recipients or recipients infected with <italic>L. monocytogenes</italic> 1 day before mTomato<sup>+</sup> cell perfusion (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). We found that 2 days after mTomato<sup>+</sup> cell perfusion, engrafted mTomato<sup>+</sup> CXCR4<sup>high</sup> MKs more efficiently infiltrated into the liver (92.1%) and spleen (92.5%); by contrast, most mTomato<sup>+</sup> CXCR4<sup>low</sup> MKs (66.7%) migrated to the bone marrow (<xref ref-type="fig" rid="fig4">Figure 4K</xref>).</p><p>As the lung is an important site for platelet generation (<xref ref-type="bibr" rid="bib43">Lefrançais et al., 2017</xref>), we aligned our MK sc-RNAseq data with lung MKs (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>), and found that MK5, MK4, and MK3 showed similar gene profiles with lung MKs (<xref ref-type="fig" rid="fig4">Figure 4L</xref>). Moreover, MK5 enriched more inflammatory pathway genes, antigen processing, and presentation pathway after <italic>L. monocytogenes</italic> infection, which enabled MK5 to achieve a more similar transcriptional profile as the lung MKs than normal MK5 (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>). Interestingly, we found that engrafted Tomato<sup>+</sup> MKs (from <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice) more efficiently infiltrated the lungs in the infected recipients as extravascular MKs than in the control recipients (<xref ref-type="fig" rid="fig4">Figure 4M–O</xref> and <xref ref-type="fig" rid="fig4s6">Figure 4—figure supplement 6</xref>).</p></sec><sec id="s2-5"><title>Acute inflammation-induced emergency megakaryopoiesis generates CXCR4<sup>high</sup> MKs upon infection</title><p>Infection-induced emergency megakaryopoiesis compensates the platelet consumption (<xref ref-type="bibr" rid="bib72">Verschoor et al., 2011</xref>). Consistently, we observed that MKs were ruptured in the bone marrow 3 days after <italic>L. monocytogenes</italic> infection to recover the reduced platelets post-<italic>L. monocytogenes</italic> infection (<xref ref-type="bibr" rid="bib12">Couldwell and Machlus, 2019</xref>; <xref ref-type="bibr" rid="bib52">Nishimura et al., 2015</xref>; <xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). However, CXCR4<sup>high</sup> MKs were increased at 18 hr after <italic>L. monocytogenes</italic> infection and substantially declined at 72 hr in bone marrow, whereas CXCR4<sup>low</sup> MKs remained unchanged upon infection (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). As MK-committed HSCs drive infection-induced emergency megakaryopoiesis (<xref ref-type="bibr" rid="bib29">Haas et al., 2015</xref>), we asked whether emergency megakaryopoiesis also generates CXCR4<sup>high</sup> MKs to participate in the host-defense response. To this aim, we employed <italic>Scl<sup>CreER</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice (<xref ref-type="bibr" rid="bib28">Göthert et al., 2005</xref>) to monitor the HSPC derived emergency megakaryopoiesis upon bacterial infection. Eighteen hours after tamoxifen recombining Tomato in HSPCs and <italic>L. monocytogenes</italic> infection (<xref ref-type="fig" rid="fig5">Figure 5E</xref>), we observed that Tomato<sup>+</sup> HSPCs derived Tomato<sup>+</sup> CXCR4<sup>high</sup> MKs rapidly increased in the bone marrow, similar to the platelet-generating MKs (tdTomato<sup>+</sup> CXCR4<sup>low</sup> MKs) (<xref ref-type="fig" rid="fig5">Figure 5F</xref>), without a noticeable rise of hematopoietic progenitors (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Overall, our observations indicated that CXCR4<sup>high</sup> MKs might be generated by emergency megakaryopoiesis to stimulate pathogen defense.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Acute inflammation induces emergency megakaryopoiesis of CXCR4<sup>high</sup> MKs.</title><p>(<bold>A–B</bold>) Representative images (<bold>A</bold>) and statistical analysis (<bold>B</bold>) of CD41 (green) and DAPI (blue) in bone marrow from control mice or mice 3 days after <italic>L. monocytogenes</italic> infection. Arrows indicate ruptured MKs, yellow boxes indicate the locations of the magnified images. (<bold>C</bold>) Platelets in peripheral blood in control mice or mice after <italic>L. monocytogenes</italic> infection on indicated days. (<bold>D</bold>) The dynamics percentage of CXCR4<sup>high</sup> MKs (left) or CXCR4<sup>low</sup> MKs (right) in the bone marrow of <italic>L. monocytogenes</italic>-challenged mice within 72 hr of infection. (<bold>E</bold>) Schema for HSC lineage tracing upon <italic>L. monocytogenes</italic> infection using <italic>Scl<sup>CreER</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs-tdTomato</sup></italic><sup>+/-</sup> mice. (<bold>F–G</bold>) Cell numbers of tdTomato<sup>+</sup> CXCR4<sup>low</sup> MKs and tdTomato<sup>+</sup> CXCR4<sup>high</sup> MKs (<bold>F</bold>), and tdTomato<sup>+</sup> progenitors (<bold>G</bold>) in the bone marrow of control and <italic>L. monocytogenes</italic> infected <italic>Scl<sup>CreER</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs-tdTomato</sup></italic><sup>+/-</sup> recipients 18 hr after <italic>L. monocytogenes</italic> infection and tamoxifen administration. CMP, common myeloid progenitor; GMP, granulocyte-monocyte progenitor; MEP, megakaryocyte-erythroid progenitor. Scale bars, 20 μm. Data represent mean ± s.e.m. Two-tailed Student’s <italic>t</italic>-test was performed to assess statistical significance, * p&lt;0.05, ** p&lt;0.01, n.s., not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78662-fig5-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>MKs participate in megakaryocyte maturation, platelet activation, and potentially influence neutrophils and the adaptive immune cells (<xref ref-type="bibr" rid="bib15">Cunin and Nigrovic, 2019</xref>). Accordingly, MKs prevent the spread of dengue virus infection by enhancing the type 1 interferons pathway in murine and clinical biospecimens (<xref ref-type="bibr" rid="bib10">Campbell et al., 2019</xref>) and contribute to cytokine storms in severe COVID-19 patients (<xref ref-type="bibr" rid="bib5">Bernardes et al., 2020</xref>; <xref ref-type="bibr" rid="bib58">Ren et al., 2021</xref>; <xref ref-type="bibr" rid="bib65">Stephenson et al., 2021</xref>). MKs were reported to express multiple inflammation receptors, such as Fcγ receptors (<xref ref-type="bibr" rid="bib47">Markovic et al., 1995</xref>), Toll-like receptors (<xref ref-type="bibr" rid="bib4">Beaulieu et al., 2011</xref>; <xref ref-type="bibr" rid="bib76">Ward et al., 2005</xref>), interleukin receptors (<xref ref-type="bibr" rid="bib50">Navarro et al., 1991</xref>; <xref ref-type="bibr" rid="bib80">Yang et al., 2000</xref>), and IFN receptors (<xref ref-type="bibr" rid="bib51">Negrotto et al., 2011</xref>), which might enable MKs to receive inflammation signals and express cytokines. Recent scRNA-seq studies suggested the existence of MK subpopulations for inflammation responses (<xref ref-type="bibr" rid="bib45">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib74">Wang et al., 2021a</xref>). Here, we identified that MK5 has both MK and immune cell characteristics for platelet generation and immune responses. More importantly, we demonstrated that CXCR4<sup>high</sup> MKs recruited and stimulated innate myeloid cells by producing TNFα and IL-6, for bacterial phagocytosis. Furthermore, CXCR4<sup>high</sup> MKs had the ability for antigen processing and antigen presentation capacity, which suggested that CXCR4<sup>high</sup> MKs might contribute to the regulation of adaptive immune function. This is consistent with a previous observation that lung MKs are able to process and present antigens (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>). Our data suggested that CXCR4<sup>high</sup> MKs might contribute to the regulation of adaptive immune function. However, as the distinction between CXCR4<sup>high</sup> MKs and CXCR4<sup>low</sup> MKs is not entirely objective, additional markers are warranted to further enrich CXCR4<sup>high</sup> MKs.</p><p>We observed that MK ablation increased HSPCS and myeloid granulocyte/macrophage progenitor (GMP) in bone marrow under bacterial infection, which is consistent with 5-FU stress (<xref ref-type="bibr" rid="bib33">Hérault et al., 2017</xref>). However, increased GMP only increased myeloid cells in the bone marrow but not in other organs, which further supported the role of CXCR4<sup>high</sup> MKs in promoting the migration of myeloid cells. Normal HSC to MK development takes 11–12 days in humans and 4 days in mice; However, emergency megakaryopoiesis takes less than a day to generate MKs upon inflammation stress (<xref ref-type="bibr" rid="bib12">Couldwell and Machlus, 2019</xref>; <xref ref-type="bibr" rid="bib45">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Sun et al., 2021</xref>; <xref ref-type="fig" rid="fig5">Figure 5D</xref>). Previously, researchers believed that emergency megakaryopoiesis mainly contributes to the replenishment of damaged platelets upon acute inflammation (<xref ref-type="bibr" rid="bib29">Haas et al., 2015</xref>). We found that inflammation signals could not upregulate CXCR4 in CXCR4<sup>low</sup> MKs in vitro, although we cannot entirely exclude the plasticity of MKs in vivo. Our data showed that CXCR4<sup>high</sup> MKs might be generated from the emergency megakaryopoiesis, instead of CXCR4<sup>low</sup> MKs, to facilitate host-defense responses against bacterial infection.</p><p>A recent report showed that the lung is a reservoir of MKs for platelet production (<xref ref-type="bibr" rid="bib43">Lefrançais et al., 2017</xref>). Other works also indicate that lung MKs share a similar transcriptional profile with lung DCs and participate in pathogen infection (<xref ref-type="bibr" rid="bib7">Boilard and Machlus, 2021</xref>; <xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>). However, the correspondence between MKs in the lung and bone marrow remains unexplored. Neonatal lung MKs lack the immune molecules in adult lung MKs (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>), which indicates that lung MKs might have distinct developmental origins. Similarly, MKs are observed to egress and migrate to the pulmonary capillary under stresses (<xref ref-type="bibr" rid="bib17">Davis et al., 1997</xref>). Our works suggested lung MKs might migrate from bone marrow upon infection challenges, although more detailed investigations are warranted in future studies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD41a (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#17-0411-82<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1603237">AB_1603237</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CXCR4 (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#53-9991-80 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_953573">AB_953573</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD11b (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#12-0112-82 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2734869">AB_2734869</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-F4/80 (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#17-4801-80 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2784647">AB_2784647</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Gr-1 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#108424 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2137485">AB_2137485</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Ly-6C (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#128022 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10639728">AB_10639728</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD11c (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#12-0114-82 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_465552">AB_465552</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD45.1 (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#15-0453-82 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_468759">AB_468759</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD45.2 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#109831 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10900256">AB_10900256</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD4 (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#12-0041-82 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_465506">AB_465506</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD8a (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#100707 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312746">AB_312746</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IFN-γ (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#505813 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_493312">AB_493312</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IL-4 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#504118 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10898116">AB_10898116</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD34 (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#11-0341-82 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_465021">AB_465021</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Sca-1 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#108114 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_493596">AB_493596</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-c-Kit (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#105812 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_313221">AB_313221</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD135 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#135314 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2562339">AB_2562339</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD3ε (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#100310 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312675">AB_312675</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-B220 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#103210 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312995">AB_312995</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TER-119 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#116210 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_313711">AB_313711</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IgM (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#15-5790-82 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_494222">AB_494222</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD16/32 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#101333 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2563692">AB_2563692</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD127 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#135021 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1937274">AB_1937274</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TNFα (mouse monoclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#17-7321-81 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_469507">AB_469507</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)<break/>IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IL-6 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#504507 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10694868">AB_10694868</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)<break/>IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-BrdU (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#11-5071-42 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11042627">AB_11042627</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Endomucin (mouse polyclonal)</td><td align="left" valign="bottom">R&amp;D</td><td align="left" valign="bottom">Cat#AF4666</td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD150 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#115908 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_345278">AB_345278</ext-link></td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Lineage Panel (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#133307 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11124348">AB_11124348</ext-link></td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Goat AF488 (goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#A32814 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2762838">AB_2762838</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TNF-alpha (mouse monoclonal)</td><td align="left" valign="bottom">Sino Biological</td><td align="left" valign="bottom">Cat#50349-R023</td><td align="left" valign="bottom">2 μg ml<sup>–1</sup></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Rabbit AF488 (rabbit polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#R37118 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2556546">AB_2556546</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-OVA257-264 (SIINFEKL) peptide bound to H-2K<sup>b</sup> (mouse monoclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#17-5743-82 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1311286">AB_1311286</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IL-2 (mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat#25-7021-80 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1235007">AB_1235007</ext-link></td><td align="left" valign="bottom">FACS (1 μl per test)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Diphtheria toxin (DT)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat#D0564-1MG</td><td align="left" valign="bottom">40 μg kg<sup>–1</sup> body mass</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BrdU (5-Bromo-2´-Deoxyuridine)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat#B5002-250mg</td><td align="left" valign="bottom">125 mg kg<sup>–1</sup> body mass</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CFSE (5-Carboxyfluorescein, Succinimidyl Ester)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#C2210</td><td align="left" valign="bottom">2.5 μM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">GM-CSF</td><td align="left" valign="bottom">Abbkine</td><td align="left" valign="bottom">Cat#PRP2116</td><td align="char" char="." valign="bottom">10 ng ml<sup>–1</sup></td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">IL-4</td><td align="left" valign="bottom">novoprotein</td><td align="left" valign="bottom">Cat#CK15</td><td align="char" char="." valign="bottom">10 ng ml<sup>–1</sup></td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tamoxifen</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat#T5648</td><td align="left" valign="bottom">20 mg ml<sup>–1</sup> corn oil</td></tr><tr><td align="left" valign="bottom">Commercial kit</td><td align="left" valign="bottom">Chromium Single Cell 3′ GEM, Library &amp; Gel Bead Kit v3</td><td align="left" valign="bottom">10 x Genomics</td><td align="left" valign="bottom">PN-1000075</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial kit</td><td align="left" valign="bottom">Chromium Chip B Single Cell Kit</td><td align="left" valign="bottom">10 x Genomics</td><td align="left" valign="bottom">PN-1000074</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">NCTC clone 929</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">CCL-1<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0462">CVCL_0462</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">B3Z hybridoma CD8 T cell</td><td align="left" valign="bottom">Dr. Nilabh Shastri</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">scRNA sequencing data (raw and processed data)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">GEO: GSE168224</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6 J</td><td align="left" valign="bottom">Shanghai Model Organisms</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Tg(Pf4-icre)Q3Rsko/J (<italic>Pf4<sup>Cre</sup></italic>)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock No: 008535</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Gt(ROSA) 26Sortm1(HBEGF) Awai/J (<italic>Rosa26<sup>fs-iDTR</sup></italic>)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock No: 007900</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (<italic>Rosa26<sup>fs-mTmG</sup></italic>)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock No: 007576</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J (<italic>Rosa26<sup>fs-tdTomato</sup></italic>)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock No: 007905</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Scl<sup>CreER</sup></italic> mice</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Göthert et al., 2005</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Cxcl12tm2.1Sjm/J (<italic>Cxcl12<sup>fs-DsRed</sup></italic>)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock No: 022458</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6-Tg(TcraTcrb)1,100Mjb/J (<italic>OT-I</italic>)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock No: 003831</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (L. monocytogenes)</td><td align="char" char="." valign="bottom">10403 S</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib6">Bishop and Hinrichs, 1987</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cell ranger_3.0.2</td><td align="left" valign="bottom">10 x Genomics</td><td align="left" valign="bottom">tenx<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_01695">SCR_01695</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R_3.6.3</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/">https://cran.r-project.org/</ext-link></td><td align="left" valign="bottom">R 3.6.3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Seurat_3.0.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib9">Butler et al., 2018</xref></td><td align="left" valign="bottom">Seurat<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016341">SCR_016341</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ggplot2_3.2.0</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggplot2/index.html">https://cran.r-project.org/web/packages/ggplot2/index.html</ext-link></td><td align="left" valign="bottom">ggplot2 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014601">SCR_014601</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">clusterProfiler_3.12.0</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib82">Yu et al., 2012</xref></td><td align="left" valign="bottom">clusterProfiler RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016884">SCR_016884</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">pheatmap_1.0.12</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/pheatmap/">https://cran.r-project.org/web/packages/pheatmap/</ext-link></td><td align="left" valign="bottom">pheatmap RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016418">SCR_016418</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CellPhoneDB_2.1.7</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib24">Efremova et al., 2020</xref></td><td align="left" valign="bottom">CellPhoneDB RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017054">SCR_017054</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CellChat_1.1.3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib37">Jin et al., 2021</xref></td><td align="left" valign="bottom">CellChat 1.1.3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">symphony_1.0</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Kang et al., 2021</xref></td><td align="left" valign="bottom">symphony 1.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MetaNeighbor_1.10.0</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib13">Crow et al., 2018</xref></td><td align="left" valign="bottom">MetaNeighbor RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016727">SCR_016727</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">iMAP_1.0.0</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib75">Wang et al., 2021b</xref><break/></td><td align="left" valign="bottom">iMAP 1.0.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">scmap_ 1.16.0</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Kiselev et al., 2018</xref></td><td align="left" valign="bottom">Scmap RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017338">SCR_017338</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">enrichplot_1.4.0</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib83">Yu, 2019</xref></td><td align="left" valign="bottom">enrichplot 1.4.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Imaris_8.4</td><td align="left" valign="bottom">Bitplane</td><td align="left" valign="bottom">Imaris RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007370">SCR_007370</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo_10</td><td align="left" valign="bottom">BD Bioscience</td><td align="left" valign="bottom">FlowJo RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008520">SCR_008520</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ_ 1.8.0</td><td align="left" valign="bottom">National Institutes of Health</td><td align="left" valign="bottom">ImageJ RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat#D1306</td><td align="left" valign="bottom">IF (0.5 µg/mL)</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Corn oil</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat#PHR2897</td><td align="left" valign="bottom">Tamoxifen dissolution</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Lymphocyte Separation Medium</td><td align="left" valign="bottom">TBD Science</td><td align="left" valign="bottom">Cat#LTS1077</td><td align="left" valign="bottom">Liver cell isolation</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>C57BL/6-Tg(<italic>Pf4-cre</italic>)Q3Rsko/J (<italic>Pf4<sup>Cre</sup></italic>), C57BL/6-Gt(ROSA) 26Sortm1(HBEGF) Awai/J (<italic>Rosa26<sup>fs-iDTR</sup></italic>), C57BL/6-<italic>Gt(ROS</italic>A)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (<italic>Rosa26<sup>fs-mTmG</sup></italic>), Gt(ROSA)26Sortm9(CAG-tdTomato)Hze (<italic>Rosa26<sup>fs-tdTomato</sup></italic>), CXCL12tm2.1Sjm/J (<italic>Cxcl12<sup>DsRed</sup></italic>) and C57BL/6-Tg(TcraTcrb)1,100Mjb/J (<italic>OT-I</italic>) mice were obtained from the Jackson Laboratory. <italic>Scl<sup>CreER</sup></italic> mice were provided by J. R. Göthert. All mice were maintained in the C57BL/6 background. Animals were blindly included in the experiments according to genotyping results as a mix of male and female. All animal experiments were performed according to protocols approved by the Sun Yat-sen University animal care and use committee (approval No. SYSU-IACUC-2021-B0617).</p></sec><sec id="s4-2"><title>Cell line</title><p>B3Z hybridoma T cells were kindly gifted by Dr. Nilabh Shastri (Johns Hopkins University). This cell line was verified to be mycoplasma free by EZdetect PCR Kit for Mycoplasma Detection (HiMedia).</p></sec><sec id="s4-3"><title>Bacteria and infections</title><p><italic>Listeria</italic> (<italic>L</italic>.) <italic>monocytogenes</italic> infection was performed as described with minor modifications (<xref ref-type="bibr" rid="bib23">Edelson and Unanue, 2000</xref>; <xref ref-type="bibr" rid="bib72">Verschoor et al., 2011</xref>). In brief, wild-type <italic>L. monocytogenes</italic> strain 10,403 S grown to exponential phase at 37 °C in TSB media was injected intravenously at a dose of 2500 colony-forming units (CFUs) to determine spleen and liver bacterial burdens 3 days after infection. Recombinant <italic>L. monocytogenes</italic> expressing the chicken ovalbumin peptide (OVA<sub>257-264</sub>) (<italic>L.m</italic>. – OVA<sub>257-264</sub>) was injected intravenously at a dose of 2500 CFUs to determine activated spleen T cells 7 days after infection. <italic>Escherichia</italic> (<italic>E</italic>.) <italic>coli</italic> wild-type strain 85,344 expressing GFP was constructed as previously described (<xref ref-type="bibr" rid="bib25">Feng et al., 2020</xref>). GFP-labeled <italic>E. coli</italic> was grown to exponential phase at 37 °C in LB media and washed with PBS before being suspended for phagocytosis assays.</p></sec><sec id="s4-4"><title>Antibodies for flow cytometry analysis and cell sorting</title><p>For cell sorting and analysis, monoclonal antibodies to CD41 (MWReg30, eBioscience), CXCR4 (2B11, eBioscience), CD11b (M1/70, eBioscience), F4/80 (BM8, eBioscience), Gr-1 (RB6-8C5, Biolegend), Ly6C (HK1.4, Biolegend), CD11c (N418, eBioscience), CD45.1 (A20, eBioscience), CD45.2 (104, Biolegend), CD4 (GK1.5, eBioscience), CD8 (53–6.7, Biolegend), INF-γ (XMG1.2, Biolegend), IL4 (11B11, Biolegend), CD34 (RAM34, eBioscience), Sca-1 (D7, Biolegend), c-kit (2B8, Biolegend), CD135 (A2F10, Biolegend), CD3ε (145–2 C11, Biolegend), CD45R (RA3-6B2, Biolegend), TER-119 (Ter-119, Biolegend), IgM (II/41, eBioscience), FγRII (93, Biolegend), IL-7R (A7R34, Biolegend), TNFα (MP6-XT22, Invitrogen), IL-6 (MP5-20F3, Biolegend), OVA257-264 (SIINFEKL) peptide bound to H-2K<sup>b</sup> (eBio25-D1.16 (25-D1.16), Invitrogen) and IL-2 (JES6-5H4, eBioscience) were used where indicated.</p></sec><sec id="s4-5"><title>Flow cytometry and cell sorting</title><p>Bone marrow cells were isolated from mouse femora and tibiae as previously reported (<xref ref-type="bibr" rid="bib36">Jiang et al., 2018</xref>). Splenocytes were mechanically dissociated in PBS with 2% FBS. Peripheral blood was collected from the retro‐orbital sinus and anticoagulated by K2-EDTA. Those three kinds of cells then underwent red blood cell lysis for 5 min using 0.16 M ammonium chloride solution. Liver cells were mechanically dissociated and lysed using 0.16 M ammonium chloride solution, followed by gradient sedimentation using a density reagent (LTS1077, TBD Science) following the manufacturer’s instruction. Cell sorting was performed using a cell sorter (MoFlo Astrios, Beckman Coulter) with a 100 μm nozzle at a speed of around 5000 cells s<sup>–1</sup>. For intracellular cytokine staining, cells were pretreated with Brefeldin-A (BFA, 10 μg ml<sup>–1</sup>) for 4 hr at 37℃ before staining. For MK antigen presentation detection, MKs were co-culture with 100 μg ml<sup>–1</sup> soluble full-length OVA for 24 hr before staining. For IFNγ, LPS and <italic>L. monocytogenes</italic> treatment, cells were co-culture with 10 ng ml<sup>–1</sup> IFN-γ or 30 μg ml<sup>–1</sup> LPS for 4, 18, or 24 hr, or 10<sup>6</sup> <italic>L. monocytogenes</italic> for 4 hr in a 37℃ incubator before staining. Cell analysis was performed on either one of the flow cytometers (Attune NxT, Thermo Fisher; Cytek AURORA, Aurora).</p></sec><sec id="s4-6"><title>Single-cell library construction and sequencing</title><p>Sorted CD41<sup>+</sup> FSC<sup>high</sup> single cells from four mice of a control MK group and an MK group from mice 3 days upon <italic>L. monocytogenes</italic> infection each were processed through the Chromium Single Cell Platform using the Chromium Single Cell 3’ Library and Gel Bead Kit v3 (PN-1000075, 10 x Genomics) and the Chromium Single Cell B Chip Kit (PN-1000074, 10 x Genomics) as the manufacturer’s protocol. In brief, over 7000 cells were loaded onto the Chromium instrument to generate single-cell barcoded droplets. Cells were lysed and barcoded reverse transcription of RNA occurred. The library was prepared by following amplification, fragmentation, adaptor, and index attachment then sequenced on an Illumina NovaSeq platform.</p></sec><sec id="s4-7"><title>scRNA-seq processing</title><p>The scRNA-seq reads were aligned to the mm10 reference genomes, and unique molecular identifier (UMI) counts were obtained by Cell Ranger 3.0.2. Normalization, dimensionality reduction, and clustering were performed with the Seurat 3.0 R package (<xref ref-type="bibr" rid="bib9">Butler et al., 2018</xref>). For the control and <italic>Listeria</italic> (<italic>L</italic>.) <italic>monocytogenes</italic> infection group, we loaded one 10 x Genomics well each and detected 5663 and 5948 cells that passed the Cell Ranger pipeline, respectively. To ruled out low quality cells, cells with &gt;12% mitochondrial content or &lt;200 detected genes were excluded with Seurat function subset (percent.mt &lt;12 &amp; nFeature_RNA &gt;200). We ruled out doublets with default parameters of DoubletDecon R package, and 54 control cells and 939 <italic>L</italic>. <italic>monocytogenes</italic> infected cells were excluded. Following the standard procedure in Seurat’s pipeline, we identified 3272 MKs from control mice (1712 MKs) and mice with <italic>L. monocytogenes</italic> infection (1560 MKs) (3897 and 3449 immune cells were discarded, respectively) in combination with MetaNeighbor method. Preprocessed dataset normalization was performed by dividing the UMI counts per gene by the total UMI counts in the corresponding cell and log-transforming before scaling and centering. SCT normalization was performed with the script: object &lt;- SCTransform(object, vars.to.regress = “&quot;percent.mt”&quot;, verbose = FALSE). Signature genes of each cluster were obtained using the Seurat function FindMarkers with Wilcox test with fold change &gt;1.5 and p value &lt;0.05 after clustering. Heatmaps, individual UMAP plots, and violin plots were generated by the Seurat functions in conjunction with ggplot2 and pheatmap R packages.</p><p>Similarities and UMAP projection between our scRNA-seq data and published datasets GSE152574 (<xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>), GSE158358 (<xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>), GSE137540 (<xref ref-type="bibr" rid="bib78">Xie et al., 2020</xref>), GSE128074 (<xref ref-type="bibr" rid="bib31">Hamey et al., 2021</xref>), or GSE132042 (<xref ref-type="bibr" rid="bib2">Almanzar et al., 2020</xref>) were conducted by MetaNeighbor R package (<xref ref-type="bibr" rid="bib13">Crow et al., 2018</xref>), iMAP.py and Symphony R package (<xref ref-type="bibr" rid="bib39">Kang et al., 2021</xref>). iMAP integration was performed using the default parameters except n_top_genes = 2000, min_genes = 0, min_cells = 0, and n_epochs = 100 before doing dimensionality reduction using Uniform Manifold Approximation and Projection method (UMAP, n_neighbors = 30, n_pca = 30). Radar charts were generated with JavaScript written by Nadieh Bremer (<ext-link ext-link-type="uri" xlink:href="https://www.visualcinnamon.com/">https://www.visualcinnamon.com/</ext-link>). Euclidean distances denote the distances between the centroid of each cluster.</p><p>Correlations were calculated based on normalized RNA values, with the function cor and the parameter ‘method = “spearman”’. Multiple testing correction using the function cor.test with the parameter “method = “spearman” and it was applied for <italic>Cxcr4</italic> expression correlations. We calculated the similarities between MK1 to 5 with the published MK, immune cell, and myeloid progenitor datasets (<xref ref-type="bibr" rid="bib2">Almanzar et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Hamey et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Pariser et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Xie et al., 2020</xref>; <xref ref-type="bibr" rid="bib81">Yeung et al., 2020</xref>) using scmap R package (<xref ref-type="bibr" rid="bib41">Kiselev et al., 2018</xref>). Default parameters and 1000 features were used and threshold &gt;0 was set. Cell-type matches are selected based on the highest value of similarities and the second-highest value which is not 0.01 less than the highest value across all reference cell types.</p><p>Cytokine, inflammatory, chemokine, and antigen processing and presentation scores were evaluated with the AddModuleScore function of Seurat using genes from KEGG pathway ko04060, cytokine-cytokine receptor interaction; GO:0006954, inflammatory response; chemokine ligands from CellPhoneDB.mouse (<xref ref-type="bibr" rid="bib37">Jin et al., 2021</xref>) and GO:0019882, antigen processing and presentation.</p><p>Interaction analysis of MKs and immune cells were conducted by CellPhoneDB (<xref ref-type="bibr" rid="bib24">Efremova et al., 2020</xref>) (transformed to human orthologous genes <xref ref-type="bibr" rid="bib16">Davidson et al., 2020</xref>) and CellChat R package (<xref ref-type="bibr" rid="bib37">Jin et al., 2021</xref>). Only interactions involving cytokines were shown. Gene Ontology (GO) analysis was performed using clusterProfiler R package (<xref ref-type="bibr" rid="bib82">Yu et al., 2012</xref>) and visualized using enrichplot R package (<xref ref-type="bibr" rid="bib83">Yu, 2019</xref>).</p><p>Gene set enrichment analysis (GSEA) was performed using gsea R package (<xref ref-type="bibr" rid="bib66">Subramanian et al., 2005</xref>) and visualized using enrichplot R package. Gene lists were pre-ranked by the fold change values of the differential expression analysis using Seurat function FindMarkers. Gene sets for GSEA were obtained from GO database (GO:0002367, cytokine production involved in immune response; GO:0006954, inflammatory response; GO:0008009, chemokine activity; GO:0022409, positive regulation of cell-cell adhesion; GO:0002275, myeloid cell activation involved in immune response).</p><p>Gene set variation analysis (GSVA) was performed using GSVA R package (<xref ref-type="bibr" rid="bib32">Hänzelmann et al., 2013</xref>). GSVA was performed to calculate GSVA score of indicated pathway genes in single cell datasets with the whole protein encoding genes after log normalization of expression values. Gene sets for GSVA were obtained from GO database (GO:0022409, positive regulation of cell-cell adhesion; GO:0002275, myeloid cell activation involved in immune response; GO:0002367, cytokine production involved in immune response; GO:0007596, blood coagulation; GO:0019882, antigen processing and presentation; GO:0034340: response to type I interferon; GO:0034341: response to interferon-gamma; GO:0045088, regulation of innate immune response; GO:0042742, defense response to bacterium; GO:0002819, regulation of adaptive immune response; GO:1903708, positive regulation of hemopoiesis).</p></sec><sec id="s4-8"><title>Lung cells preparation for flow cytometry</title><p>Lungs were removed and digested as described with minor modifications (<xref ref-type="bibr" rid="bib43">Lefrançais et al., 2017</xref>). In brief, removed lungs were placed in 1.5 ml tubes, minced with scissors, and digested with 1 ml digestion buffer (HBSS with 1 mg ml<sup>–1</sup> collagenase D, 0.1 mg ml<sup>–1</sup> DNase I, 25 mM HEPES, 2 mM L-glutamine, and 2% FBS) for 30 min at 37℃ before filtration through a 100 μm cell strainer and red blood cell lysis for 5 min. Samples were then filtered through 70 μm strainers and resuspended for subsequent surface marker staining for flow cytometry.</p></sec><sec id="s4-9"><title>Megakaryocyte ablation induction</title><p><italic>Pf4<sup>Cre</sup></italic> mice were mated with the <italic>Rosa26<sup>fs-iDTR</sup></italic> line to generate <italic>Pf4<sup>Cre</sup>; Rosa26<sup>fs-iDTR</sup></italic> mice. Diphtheria toxin (DT, Sigma-Aldrich) was injected intraperitoneally every day at a dose of 40 ng g<sup>–1</sup> bodyweight into <italic>Pf4<sup>Cre</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs-iDTR</sup></italic><sup>+/–</sup> mice and their cre negative counterparts to induce megakaryocyte ablation as indicated.</p></sec><sec id="s4-10"><title>Cre-ER recombinase induction</title><p><italic>Scl<sup>CreER</sup></italic> mice were mated with the <italic>Rosa26<sup>fs-tdTomato</sup></italic> line to generate <italic>Scl<sup>CreER</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice. For induction of cre-ER recombinase, <italic>Scl<sup>CreER</sup></italic>, <italic>Rosa26<sup>fs-tdTomato</sup></italic><sup>+/–</sup> mice were injected with tamoxifen intraperitoneally once (2 mg in 0.1 ml corn oil; Sigma-Aldrich).</p></sec><sec id="s4-11"><title>BrdU incorporation assay</title><p>5-Bromo-2-deoxyuridine (BrdU) was administered at a single dose of 125 mg kg<sup>–1</sup> body mass by intraperitoneal injection. Whole bone marrow cells were collected 12 hr later and incubated with anti-CD41 and anti-CXCR4 for 1 hr. Cells were washed and then fixed with 4% PFA at 4 °C overnight. Cells were then permeabilized with 0.5% TritonX-100 for 15 min at room temperature and incubated with 1 mg ml<sup>–1</sup> DNase I (Roche) for 1 hr at 37 °C followed by incubating with anti-BrdU (BU20A, eBioscience) for 1 hr at room temperature before being analyzed.</p></sec><sec id="s4-12"><title>Annexin V binding assay</title><p>For Annexin V binding assay, bone marrow cells were incubated with cell surface markers for 1 hr at 4 °C and then washed with PBS before being resuspended with Annexin V binding buffer (Biolegend). Cells were then incubated with FITC Annexin V (Biolegend) for 15 min at room temperature in dark, and then 300 μl Annexin V binding buffer was added to each tube. Cells were analyzed by a flow cytometer.</p></sec><sec id="s4-13"><title>Immunostaining</title><p>Immunostaining of frozen sections was performed as described (<xref ref-type="bibr" rid="bib36">Jiang et al., 2018</xref>). For bone sections, mice were perfused with PBS and 4% paraformaldehyde (PFA). Then the bones were fixed with 4% PFA for 24 hr, decalcified with 0.5 M EDTA for 2 days, and gradient dehydrated by 15% and 30% sucrose for another 2 days. The thick of sections was 30 μm. We used CD41 (MWReg30; eBioscience; 1:200), Endomucin (R&amp;D; 1:100), CD150 (TC15-12F12.2; Biolegend; 1:100), CD48 (HM48-1; Biolegend; 1:100), CXCR4 (2B11, eBioscience; 1:100) antibodies, and lineage panel (Biolegend; cat #133307; 1:50). Secondary staining was done with donkey anti–goat AlexaFluor 488 (Invitrogen; 1:1000). For the liver and spleen from <italic>Pf4<sup>Cre+</sup>; Rosa26<sup>fs-mTmG</sup></italic><sup>+/–</sup> mice, and lung from <italic>Pf4-cre<sup>+</sup>; Rosa26<sup>fs-tdTomato</sup></italic><sup>+/–</sup> mice, we used DAPI (Thermo Fisher; 0.5 μg ml<sup>–1</sup>) to stain the frozen sections. For phagocytosis analysis, F4/80 (BM8, eBioscience; 1:100), CD11b (M1/70; Invitrogen; 1:100), CD41 (MWReg30; Thermo Fisher; 1:200) and DAPI was used. For sorted MKs, we used CXCR4 (2B11, eBioscience; 1:100), TNFα (R023, Sino Biological; 1:100) and IL-6 (MP5-20F3, Biolegend; 1:100) antibody. Secondary staining was performed with donkey anti-rabbit AlexaFluor 488 (Invitrogen; 1:1000). Confocal images were obtained using a spinning-disk confocal microscope (Dragonfly, Andor) and analyzed using Imaris 9.0 software (Oxford Instruments). Three-Dimension plots were generated using Matplotlib (<xref ref-type="bibr" rid="bib34">Hunter, 2007</xref>).</p></sec><sec id="s4-14"><title>Quantitative real-time (qRT-) PCR</title><p>For RT-qPCR, MKs were dissociated in Trizol (Magen), and RNA was extracted following the manufacture’s instruction. RNA was reverse transcribed into cDNA using the TransCript All-in-One First-Strand cDNA Synthesis kit (Transgene). Quantitative PCR was performed using a Bio-Rad CFX 96 touch. The primers for <italic>Pf4</italic> were 5’-<named-content content-type="sequence">GGGATCCATCTTAAGCACATCAC</named-content>-3’ (forward) and 5’-<named-content content-type="sequence">CCATTCTTCAGGGTGGCTATG</named-content>-3’ (reverse). The primers for <italic>Vwf</italic> were 5’-<named-content content-type="sequence">CTTCTGTACGCCTCAGCTATG</named-content>-3’ (forward) and 5’-<named-content content-type="sequence">GCCGTTGTAATTCCCACACAAG</named-content>-3’ (reverse). The primers for <italic>Mpl</italic> were 5’-<named-content content-type="sequence">AACCCGGTATGTGTGCCAG</named-content>-3’ (forward) and 5’-<named-content content-type="sequence">AGTTCATGCCTCAGGAAGTCA</named-content>-3’ (reverse). The primers for <italic>Cxcl12</italic> were 5’-<named-content content-type="sequence">AGGTTCTTATTTCACGGCTTGT</named-content>-3’ (forward) and 5’-<named-content content-type="sequence">TGGGTGCTGAGACCTTTGAT</named-content>-3’ (reverse). The primers for <italic>Gapdh</italic> were 5’-<named-content content-type="sequence">AGGTCGGTGTGAACGGATTTG</named-content>-3’ (forward) and 5’-<named-content content-type="sequence">GGGGTCGTTGATGGCAACA</named-content>-3’ (reverse). <italic>Gapdh</italic> was used as the reference gene for qRT-PCR analysis.</p></sec><sec id="s4-15"><title>Transwell migration</title><p>Transmigration assays were performed on a transwell with a pore size of 5 μm (Biofil). CXCR4<sup>low</sup> MKs or CXCR4<sup>high</sup> MKs from bone marrow were sorted (5000 cells per well) from control mice and added to the lower chamber with 600 μl IMDM (Thermo Fisher) plus 10% FBS (Gibco). Peripheral blood cells were collected as described in the ‘Flow cytometry and cell sorting’ section. 6×10<sup>5</sup> peripheral blood cells were resuspended in 100 μl RPMI 1640 (Gibco) plus 10% FBS and added to the upper insert to continue for 2-hr incubation at 37 °C, 5% CO<sub>2</sub>. Cells in the lower chamber were harvested, washed with PBS once, and resuspended with 100 μl PBS for staining and FACS counting.</p></sec><sec id="s4-16"><title>Phagocytosis</title><p>Bone-marrow-derived macrophages (BMDM) from C57BL/6 mice at 6–8 weeks of age were differentiated from bone marrow precursors with minor modifications (<xref ref-type="bibr" rid="bib48">Minutti et al., 2019</xref>). In brief, bone marrow cells were isolated and propagated for 7 days in DMEM without sodium pyruvate or HEPES (Gibco), containing 20% FBS (Gibco), 30% supernatants of L929 conditioned media, and 1% Pen/Strep (Hyclone) at 37 °C. Macrophage phagocytosis assays were performed on a transwell plate with a pore size of 3 μm (Biofil) as described with modifications (<xref ref-type="bibr" rid="bib64">Sharif et al., 2014</xref>). Briefly, attached cells were replated into 24-well plates, 5×10<sup>4</sup> cells per well, on glass coverslips for 24 hr culture. Then 5000 sorted CXCR4<sup>low</sup> MKs or CXCR4<sup>high</sup> MKs were added in the upper inserts and placed onto macrophages chambers for additional 16 hr incubation without or with 2 μg ml<sup>–1</sup> TNFα neutralizing antibody (R023, Sino Biological; 1:100) or 2 μg ml<sup>–1</sup> IL-6 neutralizing antibody (MP5-20F3, Biolegend) at 37 °C, 5% CO<sub>2</sub>. The upper inserts were discarded and macrophages were washed with PBS without antibiotics and incubated with 10<sup>5</sup> GFP-labeled <italic>E. coli</italic> for 2 hr at 37 °C, 5% CO<sub>2</sub>. Cells were washed three times with PBS and incubated with DMEM without sodium pyruvate or HEPES (Gibco) with gentamycin (50 μg ml<sup>–1</sup>) for 30 min at 37 °C, 5% CO<sub>2</sub> to remove adherent bacteria. Cells were then detected by flow cytometry or fixed by cold methanol for 15 min and blocked with 10% BSA overnight, followed by incubation with F4/80 (BM8, eBioscience; 1:100) for 2 hr at room temperature before being quantified using a spinning disk confocal microscope (Dragonfly, Andor).</p><p>For neutrophil phagocytosis, CD11b<sup>+</sup> Gr1<sup>+</sup> Ly6c<sup>–</sup> neutrophils were sorted from the spleen and propagated in RPMI 1640 (Gibco) containing 10% FBS. Neutrophil phagocytosis was performed as described in macrophage phagocytosis assay, except cells were sedimented for 30 min and fixed on glass coverslips after incubated with GFP-<italic>E. coli</italic> and gentamycin. The capacity of phagocytosis was evaluated by flow cytometry or by fluorescence intensity of GFP-<italic>E. coli</italic>. using the confocal microscope within macrophages and neutrophils.</p><p>For megakaryocyte phagocytosis, CXCR4<sup>low</sup> and CXCR4<sup>high</sup> MKs were sorted from the bone marrow and propagated in RPMI 1640 (Gibco) containing 10% FBS without antibiotics and incubated with 10<sup>5</sup> GFP-labeled <italic>E. coli</italic> for 2 hr at 37 °C, 5% CO<sub>2</sub>. Cells were washed three times with PBS and incubated with DMEM without sodium pyruvate or HEPES (Gibco) with gentamycin (50 μg ml<sup>–1</sup>) for 30 min at 37 °C, 5% CO<sub>2</sub> to remove adherent bacteria. Cells were then detected by flow cytometry.</p></sec><sec id="s4-17"><title>Bone marrow ex vivo live imaging</title><p><italic>Pf4<sup>Cre</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs-tdTomato</sup></italic><sup>+/–</sup> mice were infected with <italic>L. monocytogenes</italic> for 24 hr. FITC-Dextran (average mol wt 2000000, Sigma-Aldrich) was injected intravenously at a dose of 1.25 mg per mouse before being sacrificed. The ends of the femur below the end of the marrow cavity were cut. The bone marrow plug was gently flushed out of the end of the bone with a 21-gauge blunt needle not to break up the marrow plug. Bone marrow was flushed integrally and fixed onto a glass slide in a chamber, rinsed with RPMI 1640 (Gibco), and covered slightly with a coverslip. The integrity of the vascular structure in the bone marrow was observed and warranted through FITC-Dextran inflorescence before capturing images. Confocal images were obtained every minute on the spinning-disk confocal microscope (Dragonfly, Andor) and analyzed using Imaris 9.0 software (Oxford Instruments).</p></sec><sec id="s4-18"><title>In vitro MK culture, MK size, and proplatelet formation measurement</title><p>MKs were sorted using a cell sorter (MoFlo Astrios, Beckman Coulter) and cultured in 24-well plates in SFEM (Stem Cell Technologies) plus 100 ng ml<sup>–1</sup> mTPO (Novoprotein) and 1% Pen/Strep (Hyclone), and incubated at 37 °C, 5% CO<sub>2</sub> for 4 days. Images were taken by a Nikon Ts2R microscope equipped with a Nikon DS-Ri2 camera. Cell size and proplatelet formation were measured on day 3 or day 5 post-cultured, respectively, using Nikon NIS-Elements BR.</p></sec><sec id="s4-19"><title>Bone marrow transfer experiments</title><p><italic>Pf4<sup>Cre</sup></italic> mice were mated with the <italic>Rosa26<sup>fs-tdTomato</sup></italic> line to generate <italic>Pf4<sup>Cre</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs-tdTomato</sup></italic><sup>+/–</sup> mice. tdTomato<sup>+</sup> MKs were isolated from <italic>Pf4<sup>Cre</sup></italic><sup>+</sup>; <italic>Rosa26<sup>fs-tdTomato</sup></italic><sup>+/–</sup> mice. Six- to 8-week-old recipient mice were pre-treated with PBS or 2500 CFUs of <italic>L. monocytogenes</italic> as previously described 1 day before cell perfusion. 1×10<sup>5</sup> tdTomato<sup>+</sup> MKs were sorted and intravenously injected into control or <italic>L. monocytogenes</italic> infected mice. tdTomato<sup>+</sup> MKs were detected in lungs with immunostaining 2 days after cell perfusion.</p><p>mtdTomato<sup>+</sup> bone marrow cells were isolated from <italic>Pf4<sup>Cre</sup></italic><sup>–</sup>; <italic>Rosa26<sup>fs-mTmG</sup></italic><sup>+/–</sup> mice. 1×10<sup>6</sup> mtdTomato<sup>+</sup> bone marrow cells were intravenously injected into control or one-day-<italic>L. monocytogenes</italic> infected mice. mtdTomato<sup>+</sup> MKs were detected in bone marrow, liver, and spleen 2 days after cell perfusion.</p><p>For in vivo CXCR4<sup>high</sup> MK function assay in MK ablation mice, DT was intraperitoneally injected every day for 5 days. On the second and fourth days, 2×10<sup>5</sup> sorted wild-type CXCR4<sup>high</sup> MKs or CXCR4<sup>low</sup> MKs were intravenously injected into indicated groups. PBS or 2500 CFUs of <italic>L. monocytogenes</italic> as previously described were injected intravenously on the third day. Spleen and liver were harvested 3 days after infection to determine the bacterial burdens as described.</p></sec><sec id="s4-20"><title>T cell reactivation in vitro</title><p>Splenocytes (1×10<sup>6</sup> cells well<sup>–1</sup>) from control or MK ablated mice after 7 days <italic>L.m</italic>.-OVA infection were re-stimulated for 4 hr in vitro with OVA peptide (10 μM) in the presence of Brefeldin-A (BFA, 10 μg ml<sup>–1</sup>). Activated T cells were then analyzed by a flow cytometer.</p><p>For MK-induced T cell activation, 3×10<sup>4</sup> MK subpopulations for each sample were sorted and co-cultured with 100 μg ml<sup>–1</sup> soluble full-length OVA for 24 hr, then co-cultured with 6×10<sup>4</sup> OT-I CD8<sup>+</sup> T cells or B3Z T cells (<xref ref-type="bibr" rid="bib40">Karttunen et al., 1992</xref>) for 48 hr at 37 °C in a 5% CO<sub>2</sub> incubator as described (<xref ref-type="bibr" rid="bib85">Zufferey et al., 2017</xref>). OT-I T cell activation was detected by measuring intracellular IL-2 levels. B3Z T cell activation was detected using β-galactosidase Assay Kit (RG0036, Beyotime). Bone marrow-derived dendritic cells (DCs) were adopted as positive controls for T cell activation assay. To obtain bone marrow-derived DCs, isolated bone marrow cells were cultured in RPMI 1640 with 10 ng ml<sup>–1</sup> of GM-CSF and 10 ng ml<sup>–1</sup> of IL-4 as described (<xref ref-type="bibr" rid="bib59">Roney, 2019</xref>).</p></sec><sec id="s4-21"><title>Computational modeling of random myeloid cell localization</title><p>We have performed randomized simulations as in previous reports (<xref ref-type="bibr" rid="bib8">Bruns et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Jiang et al., 2018</xref>) in Python. Images of a 400 μm × 400 μm bone marrow region with CXCR4<sup>high</sup> and CXCR4<sup>low</sup> MKs, in which background staining was removed, were used to generate MKs onto which 200 myeloid cells were randomly placed, consistent with an average density of 200 myeloid cells per field. Each simulated run placed 200 random myeloid cells (mean diameter 5 μm) was repeated 500 times. The shortest Euclidean distance was calculated for each myeloid cell to CXCR4<sup>high</sup> or CXCR4<sup>low</sup> MKs. Random and observed distance distributions were compared using the modified nonparametric two-dimensional (2D) KS test as described (<xref ref-type="bibr" rid="bib8">Bruns et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Jiang et al., 2018</xref>).</p></sec><sec id="s4-22"><title>Statistical analyses</title><p>Data are presented as means ± s.e.m or presented medians, first and third quartiles. For phagocytosis assay and MK size measurement, data were analyzed by a one-dimensional KS test. Differences were considered statistically significant if p&lt;0.05. For the comparison of three-dimensional distances, a two-dimensional KS test was used. The difference was considered statistically significant if p&lt;0.05. For multiple comparisons analysis, data were analyzed by repeated-measures one-way analysis of variance (ANOVA) followed by Dunnett’s test. Differences were considered statistically significant if p&lt;0.05. ǂ p&lt;0.05, ǂǂ p&lt;0.01, ǂǂǂ p&lt;0.001, n.s., not significant. For pairs of measurements, data were analyzed by paired Student’s <italic>t</italic>-test. Differences were considered statistically significant if p&lt;0.05. # p&lt;0.05, ## p&lt;0.01, ### p&lt;0.001, n.s., not significant. For other experiments except for scRNA-seq analysis, data were analyzed by a two-tailed Student’s <italic>t</italic>-test. Differences were considered statistically significant if p&lt;0.05. * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001, n.s., not significant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Resources, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation</p></fn><fn fn-type="con" id="con5"><p>Data curation</p></fn><fn fn-type="con" id="con6"><p>Supervision</p></fn><fn fn-type="con" id="con7"><p>Supervision</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-78662-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The scRNA-seq data generated in this study are deposited in GEO (GSE168224, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE168224">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE168224</ext-link>). The code used in the study can be accessed at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/JYCathyXie/MK_infection">https://github.com/JYCathyXie/MK_infection</ext-link>, copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:acdb2fcb4ed49e0f1bd4acf8bdb4031fbc8efa6a;origin=https://github.com/JYCathyXie/MK_infection;visit=swh:1:snp:7279068489a5ed01450a722ff82a917067832765;anchor=swh:1:rev:687f151f79a79ad2091e3dc2c5561fc8b4bb347a">swh:1:rev:687f151f79a79ad2091e3dc2c5561fc8b4bb347a</ext-link>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Han</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Megakaryocyte derived immunoregulatory cells regulate host-defense immunity against bacterial pathogens</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE168224">GSE168224</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>AK</given-names></name><name><surname>Villacorta-Martin</surname><given-names>C</given-names></name><name><surname>Murphy</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Single Cell Transcriptomic Analysis of Lung and Hematopoietic Megakaryocytes from Embryonic and Adult Mice</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152574">GSE152574</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Pariser</surname><given-names>DN</given-names></name><name><surname>Hilt</surname><given-names>ZT</given-names></name><name><surname>Ture</surname><given-names>SK</given-names></name><name><surname>Blick-Nitko</surname><given-names>SK</given-names></name><name><surname>Looney</surname><given-names>MR</given-names></name><name><surname>Cleary</surname><given-names>SJ</given-names></name><name><surname>Roman-Pagan</surname><given-names>E</given-names></name><name><surname>Saunders</surname><given-names>J</given-names></name><name><surname>Georas</surname><given-names>SN</given-names></name><name><surname>Veazey</surname><given-names>J</given-names></name><name><surname>Madera</surname><given-names>F</given-names></name><name><surname>Santos</surname><given-names>LT</given-names></name><name><surname>Arne</surname><given-names>A</given-names></name><name><surname>Huynh</surname><given-names>NT</given-names></name><name><surname>Livada</surname><given-names>AC</given-names></name><name><surname>Guerrero-Martin</surname><given-names>SM</given-names></name><name><surname>Lyons</surname><given-names>C</given-names></name><name><surname>Metcalf-Pate</surname><given-names>KA</given-names></name><name><surname>McGrath</surname><given-names>KE</given-names></name><name><surname>Palis</surname><given-names>J</given-names></name><name><surname>Morrell</surname><given-names>CN</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Lung Megakaryocytes are Immune Modulatory Cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE158358">GSE158358</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137540">GSE137540</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Hamey</surname><given-names>FK</given-names></name><name><surname>Lau</surname><given-names>WW</given-names></name><name><surname>Diamanti</surname><given-names>E</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Dahlin</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Single-cell RNA sequencing of basophils from mouse bone marrow</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE128074">GSE128074</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><collab>Tabula Muris Consortium</collab></person-group><year iso-8601-date="2019">2019</year><data-title>Expression profiling by high throughput sequencing</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE132042">GSE132042</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the National Key Research and Development Program of China (2018YFA0107200), the National Natural Science Foundation of China (82170112, 81900101), The Key Research and Development Program of Guangdong Province (2019B020234002), China Postdoctoral Science Foundation (2021M693614), Guangdong Innovative and Entrepreneurial Research Team Program (2016ZT06S029, 2019ZT08Y485), Sanming Project of Medicine in Shenzhen (No.SZSM201911004) for generous support.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aburima</surname><given-names>A</given-names></name><name><surname>Berger</surname><given-names>M</given-names></name><name><surname>Spurgeon</surname><given-names>BEJ</given-names></name><name><surname>Webb</surname><given-names>BA</given-names></name><name><surname>Wraith</surname><given-names>KS</given-names></name><name><surname>Febbraio</surname><given-names>M</given-names></name><name><surname>Poole</surname><given-names>AW</given-names></name><name><surname>Naseem</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Thrombospondin-1 promotes hemostasis through modulation of camp signaling in blood platelets</article-title><source>Blood</source><volume>137</volume><fpage>678</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1182/blood.2020005382</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almanzar</surname><given-names>N</given-names></name><name><surname>Antony</surname><given-names>J</given-names></name><name><surname>Baghel</surname><given-names>AS</given-names></name><name><surname>Bakerman</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A single-cell transcriptomic atlas characterizes ageing tissues in the mouse</article-title><source>Nature</source><volume>583</volume><fpage>590</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2496-1</pub-id><pub-id pub-id-type="pmid">32669714</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avecilla</surname><given-names>ST</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Tejada</surname><given-names>R</given-names></name><name><surname>Liao</surname><given-names>F</given-names></name><name><surname>Shido</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>DK</given-names></name><name><surname>Dias</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Hartman</surname><given-names>TE</given-names></name><name><surname>Hackett</surname><given-names>NR</given-names></name><name><surname>Crystal</surname><given-names>RG</given-names></name><name><surname>Witte</surname><given-names>L</given-names></name><name><surname>Hicklin</surname><given-names>DJ</given-names></name><name><surname>Bohlen</surname><given-names>P</given-names></name><name><surname>Eaton</surname><given-names>D</given-names></name><name><surname>Lyden</surname><given-names>D</given-names></name><name><surname>de Sauvage</surname><given-names>F</given-names></name><name><surname>Rafii</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis</article-title><source>Nature Medicine</source><volume>10</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/nm973</pub-id><pub-id pub-id-type="pmid">14702636</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>LM</given-names></name><name><surname>Lin</surname><given-names>E</given-names></name><name><surname>Morin</surname><given-names>KM</given-names></name><name><surname>Tanriverdi</surname><given-names>K</given-names></name><name><surname>Freedman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulatory effects of TLR2 on megakaryocytic cell function</article-title><source>Blood</source><volume>117</volume><fpage>5963</fpage><lpage>5974</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-09-304949</pub-id><pub-id pub-id-type="pmid">21454454</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardes</surname><given-names>JP</given-names></name><name><surname>Mishra</surname><given-names>N</given-names></name><name><surname>Tran</surname><given-names>F</given-names></name><name><surname>Bahmer</surname><given-names>T</given-names></name><name><surname>Best</surname><given-names>L</given-names></name><name><surname>Blase</surname><given-names>JI</given-names></name><name><surname>Bordoni</surname><given-names>D</given-names></name><name><surname>Franzenburg</surname><given-names>J</given-names></name><name><surname>Geisen</surname><given-names>U</given-names></name><name><surname>Josephs-Spaulding</surname><given-names>J</given-names></name><name><surname>Köhler</surname><given-names>P</given-names></name><name><surname>Künstner</surname><given-names>A</given-names></name><name><surname>Rosati</surname><given-names>E</given-names></name><name><surname>Aschenbrenner</surname><given-names>AC</given-names></name><name><surname>Bacher</surname><given-names>P</given-names></name><name><surname>Baran</surname><given-names>N</given-names></name><name><surname>Boysen</surname><given-names>T</given-names></name><name><surname>Brandt</surname><given-names>B</given-names></name><name><surname>Bruse</surname><given-names>N</given-names></name><name><surname>Dörr</surname><given-names>J</given-names></name><name><surname>Dräger</surname><given-names>A</given-names></name><name><surname>Elke</surname><given-names>G</given-names></name><name><surname>Ellinghaus</surname><given-names>D</given-names></name><name><surname>Fischer</surname><given-names>J</given-names></name><name><surname>Forster</surname><given-names>M</given-names></name><name><surname>Franke</surname><given-names>A</given-names></name><name><surname>Franzenburg</surname><given-names>S</given-names></name><name><surname>Frey</surname><given-names>N</given-names></name><name><surname>Friedrichs</surname><given-names>A</given-names></name><name><surname>Fuß</surname><given-names>J</given-names></name><name><surname>Glück</surname><given-names>A</given-names></name><name><surname>Hamm</surname><given-names>J</given-names></name><name><surname>Hinrichsen</surname><given-names>F</given-names></name><name><surname>Hoeppner</surname><given-names>MP</given-names></name><name><surname>Imm</surname><given-names>S</given-names></name><name><surname>Junker</surname><given-names>R</given-names></name><name><surname>Kaiser</surname><given-names>S</given-names></name><name><surname>Kan</surname><given-names>YH</given-names></name><name><surname>Knoll</surname><given-names>R</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Laue</surname><given-names>G</given-names></name><name><surname>Lier</surname><given-names>C</given-names></name><name><surname>Lindner</surname><given-names>M</given-names></name><name><surname>Marinos</surname><given-names>G</given-names></name><name><surname>Markewitz</surname><given-names>R</given-names></name><name><surname>Nattermann</surname><given-names>J</given-names></name><name><surname>Noth</surname><given-names>R</given-names></name><name><surname>Pickkers</surname><given-names>P</given-names></name><name><surname>Rabe</surname><given-names>KF</given-names></name><name><surname>Renz</surname><given-names>A</given-names></name><name><surname>Röcken</surname><given-names>C</given-names></name><name><surname>Rupp</surname><given-names>J</given-names></name><name><surname>Schaffarzyk</surname><given-names>A</given-names></name><name><surname>Scheffold</surname><given-names>A</given-names></name><name><surname>Schulte-Schrepping</surname><given-names>J</given-names></name><name><surname>Schunk</surname><given-names>D</given-names></name><name><surname>Skowasch</surname><given-names>D</given-names></name><name><surname>Ulas</surname><given-names>T</given-names></name><name><surname>Wandinger</surname><given-names>KP</given-names></name><name><surname>Wittig</surname><given-names>M</given-names></name><name><surname>Zimmermann</surname><given-names>J</given-names></name><name><surname>Busch</surname><given-names>H</given-names></name><name><surname>Hoyer</surname><given-names>BF</given-names></name><name><surname>Kaleta</surname><given-names>C</given-names></name><name><surname>Heyckendorf</surname><given-names>J</given-names></name><name><surname>Kox</surname><given-names>M</given-names></name><name><surname>Rybniker</surname><given-names>J</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Rosenstiel</surname><given-names>P</given-names></name><name><surname>Banovich</surname><given-names>NE</given-names></name><name><surname>Desai</surname><given-names>T</given-names></name><name><surname>Eickelberg</surname><given-names>O</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name><name><surname>Horvath</surname><given-names>P</given-names></name><name><surname>Kropski</surname><given-names>JA</given-names></name><name><surname>Lafyatis</surname><given-names>R</given-names></name><name><surname>Lundeberg</surname><given-names>J</given-names></name><name><surname>Meyer</surname><given-names>K</given-names></name><name><surname>Nawijn</surname><given-names>MC</given-names></name><name><surname>Nikolic</surname><given-names>M</given-names></name><name><surname>Ordovas Montanes</surname><given-names>J</given-names></name><name><surname>Pe’er</surname><given-names>D</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Rawlins</surname><given-names>E</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Reyfman</surname><given-names>P</given-names></name><name><surname>Samakovlis</surname><given-names>C</given-names></name><name><surname>Schultze</surname><given-names>J</given-names></name><name><surname>Shalek</surname><given-names>A</given-names></name><name><surname>Shepherd</surname><given-names>D</given-names></name><name><surname>Spence</surname><given-names>J</given-names></name><name><surname>Teichmann</surname><given-names>S</given-names></name><name><surname>Theis</surname><given-names>F</given-names></name><name><surname>Tsankov</surname><given-names>A</given-names></name><name><surname>Berge</surname><given-names>M</given-names></name><name><surname>Papen</surname><given-names>M</given-names></name><name><surname>Whitsett</surname><given-names>J</given-names></name><name><surname>Zaragosi</surname><given-names>LE</given-names></name><name><surname>Angelov</surname><given-names>A</given-names></name><name><surname>Bals</surname><given-names>R</given-names></name><name><surname>Bartholomäus</surname><given-names>A</given-names></name><name><surname>Becker</surname><given-names>A</given-names></name><name><surname>Bezdan</surname><given-names>D</given-names></name><name><surname>Bonifacio</surname><given-names>E</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Clavel</surname><given-names>T</given-names></name><name><surname>Colme-Tatche</surname><given-names>M</given-names></name><name><surname>Diefenbach</surname><given-names>A</given-names></name><name><surname>Dilthey</surname><given-names>A</given-names></name><name><surname>Fischer</surname><given-names>N</given-names></name><name><surname>Förstner</surname><given-names>K</given-names></name><name><surname>Frick</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19</article-title><source>Immunity</source><volume>53</volume><fpage>1296</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.11.017</pub-id><pub-id pub-id-type="pmid">33296687</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>DK</given-names></name><name><surname>Hinrichs</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Adoptive transfer of immunity to Listeria monocytogenes The influence of in vitro stimulation on lymphocyte subset requirements</article-title><source>Journal of Immunology</source><volume>139</volume><fpage>2005</fpage><lpage>2009</lpage><pub-id pub-id-type="pmid">3114382</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boilard</surname><given-names>E</given-names></name><name><surname>Machlus</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Location is everything when it comes to megakaryocyte function</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>144964</elocation-id><pub-id pub-id-type="doi">10.1172/JCI144964</pub-id><pub-id pub-id-type="pmid">33393510</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruns</surname><given-names>I</given-names></name><name><surname>Lucas</surname><given-names>D</given-names></name><name><surname>Pinho</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>J</given-names></name><name><surname>Lambert</surname><given-names>MP</given-names></name><name><surname>Kunisaki</surname><given-names>Y</given-names></name><name><surname>Scheiermann</surname><given-names>C</given-names></name><name><surname>Schiff</surname><given-names>L</given-names></name><name><surname>Poncz</surname><given-names>M</given-names></name><name><surname>Bergman</surname><given-names>A</given-names></name><name><surname>Frenette</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion</article-title><source>Nature Medicine</source><volume>20</volume><fpage>1315</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1038/nm.3707</pub-id><pub-id pub-id-type="pmid">25326802</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>RA</given-names></name><name><surname>Schwertz</surname><given-names>H</given-names></name><name><surname>Hottz</surname><given-names>ED</given-names></name><name><surname>Rowley</surname><given-names>JW</given-names></name><name><surname>Manne</surname><given-names>BK</given-names></name><name><surname>Washington</surname><given-names>AV</given-names></name><name><surname>Hunter-Mellado</surname><given-names>R</given-names></name><name><surname>Tolley</surname><given-names>ND</given-names></name><name><surname>Christensen</surname><given-names>M</given-names></name><name><surname>Eustes</surname><given-names>AS</given-names></name><name><surname>Montenont</surname><given-names>E</given-names></name><name><surname>Bhatlekar</surname><given-names>S</given-names></name><name><surname>Ventrone</surname><given-names>CH</given-names></name><name><surname>Kirkpatrick</surname><given-names>BD</given-names></name><name><surname>Pierce</surname><given-names>KK</given-names></name><name><surname>Whitehead</surname><given-names>SS</given-names></name><name><surname>Diehl</surname><given-names>SA</given-names></name><name><surname>Bray</surname><given-names>PF</given-names></name><name><surname>Zimmerman</surname><given-names>GA</given-names></name><name><surname>Kosaka</surname><given-names>Y</given-names></name><name><surname>Bozza</surname><given-names>PT</given-names></name><name><surname>Bozza</surname><given-names>FA</given-names></name><name><surname>Weyrich</surname><given-names>AS</given-names></name><name><surname>Rondina</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3</article-title><source>Blood</source><volume>133</volume><fpage>2013</fpage><lpage>2026</lpage><pub-id pub-id-type="doi">10.1182/blood-2018-09-873984</pub-id><pub-id pub-id-type="pmid">30723081</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Bluteau</surname><given-names>D</given-names></name><name><surname>Debili</surname><given-names>N</given-names></name><name><surname>Vainchenker</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>From hematopoietic stem cells to platelets</article-title><source>Journal of Thrombosis and Haemostasis</source><volume>5 Suppl 1</volume><fpage>318</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1111/j.1538-7836.2007.02472.x</pub-id><pub-id pub-id-type="pmid">17635743</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couldwell</surname><given-names>G</given-names></name><name><surname>Machlus</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Modulation of megakaryopoiesis and platelet production during inflammation</article-title><source>Thrombosis Research</source><volume>179</volume><fpage>114</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.thromres.2019.05.008</pub-id><pub-id pub-id-type="pmid">31128560</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname><given-names>M</given-names></name><name><surname>Paul</surname><given-names>A</given-names></name><name><surname>Ballouz</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>ZJ</given-names></name><name><surname>Gillis</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Characterizing the replicability of cell types defined by single cell RNA-sequencing data using MetaNeighbor</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>884</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03282-0</pub-id><pub-id pub-id-type="pmid">29491377</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunin</surname><given-names>P</given-names></name><name><surname>Penke</surname><given-names>LR</given-names></name><name><surname>Thon</surname><given-names>JN</given-names></name><name><surname>Monach</surname><given-names>PA</given-names></name><name><surname>Jones</surname><given-names>T</given-names></name><name><surname>Chang</surname><given-names>MH</given-names></name><name><surname>Chen</surname><given-names>MM</given-names></name><name><surname>Melki</surname><given-names>I</given-names></name><name><surname>Lacroix</surname><given-names>S</given-names></name><name><surname>Iwakura</surname><given-names>Y</given-names></name><name><surname>Ware</surname><given-names>J</given-names></name><name><surname>Gurish</surname><given-names>MF</given-names></name><name><surname>Italiano</surname><given-names>JE</given-names></name><name><surname>Boilard</surname><given-names>E</given-names></name><name><surname>Nigrovic</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Megakaryocytes compensate for Kit insufficiency in murine arthritis</article-title><source>The Journal of Clinical Investigation</source><volume>127</volume><fpage>1714</fpage><lpage>1724</lpage><pub-id pub-id-type="doi">10.1172/JCI84598</pub-id><pub-id pub-id-type="pmid">28375155</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunin</surname><given-names>P</given-names></name><name><surname>Nigrovic</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Megakaryocytes as immune cells</article-title><source>Journal of Leukocyte Biology</source><volume>105</volume><fpage>1111</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1002/JLB.MR0718-261RR</pub-id><pub-id pub-id-type="pmid">30645026</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S</given-names></name><name><surname>Efremova</surname><given-names>M</given-names></name><name><surname>Riedel</surname><given-names>A</given-names></name><name><surname>Mahata</surname><given-names>B</given-names></name><name><surname>Pramanik</surname><given-names>J</given-names></name><name><surname>Huuhtanen</surname><given-names>J</given-names></name><name><surname>Kar</surname><given-names>G</given-names></name><name><surname>Vento-Tormo</surname><given-names>R</given-names></name><name><surname>Hagai</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Haniffa</surname><given-names>MA</given-names></name><name><surname>Shields</surname><given-names>JD</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell rna sequencing reveals a dynamic stromal niche that supports tumor growth</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107628</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107628</pub-id><pub-id pub-id-type="pmid">32433953</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>RE</given-names></name><name><surname>Stenberg</surname><given-names>PE</given-names></name><name><surname>Levin</surname><given-names>J</given-names></name><name><surname>Beckstead</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Localization of megakaryocytes in normal mice and following administration of platelet antiserum, 5-fluorouracil, or radiostrontium: evidence for the site of platelet production</article-title><source>Experimental Hematology</source><volume>25</volume><fpage>638</fpage><lpage>648</lpage><pub-id pub-id-type="pmid">9216740</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deutsch</surname><given-names>VR</given-names></name><name><surname>Tomer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Megakaryocyte development and platelet production</article-title><source>British Journal of Haematology</source><volume>134</volume><fpage>453</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2141.2006.06215.x</pub-id><pub-id pub-id-type="pmid">16856888</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deutsch</surname><given-names>VR</given-names></name><name><surname>Tomer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside</article-title><source>British Journal of Haematology</source><volume>161</volume><fpage>778</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1111/bjh.12328</pub-id><pub-id pub-id-type="pmid">23594368</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominici</surname><given-names>M</given-names></name><name><surname>Rasini</surname><given-names>V</given-names></name><name><surname>Bussolari</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Hofmann</surname><given-names>TJ</given-names></name><name><surname>Spano</surname><given-names>C</given-names></name><name><surname>Bernabei</surname><given-names>D</given-names></name><name><surname>Veronesi</surname><given-names>E</given-names></name><name><surname>Bertoni</surname><given-names>F</given-names></name><name><surname>Paolucci</surname><given-names>P</given-names></name><name><surname>Conte</surname><given-names>P</given-names></name><name><surname>Horwitz</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation</article-title><source>Blood</source><volume>114</volume><fpage>2333</fpage><lpage>2343</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-10-183459</pub-id><pub-id pub-id-type="pmid">19433859</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>F</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Hamey</surname><given-names>FK</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Ema</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis</article-title><source>Nature Cell Biology</source><volume>22</volume><fpage>630</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-0512-1</pub-id><pub-id pub-id-type="pmid">32367048</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eash</surname><given-names>KJ</given-names></name><name><surname>Means</surname><given-names>JM</given-names></name><name><surname>White</surname><given-names>DW</given-names></name><name><surname>Link</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions</article-title><source>Blood</source><volume>113</volume><fpage>4711</fpage><lpage>4719</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-09-177287</pub-id><pub-id pub-id-type="pmid">19264920</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edelson</surname><given-names>BT</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Immunity to Listeria infection</article-title><source>Current Opinion in Immunology</source><volume>12</volume><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1016/s0952-7915(00)00112-6</pub-id><pub-id pub-id-type="pmid">10899025</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efremova</surname><given-names>M</given-names></name><name><surname>Vento-Tormo</surname><given-names>M</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Vento-Tormo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes</article-title><source>Nature Protocols</source><volume>15</volume><fpage>1484</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0292-x</pub-id><pub-id pub-id-type="pmid">32103204</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>El-Sayed Ahmed</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Shen</surname><given-names>C</given-names></name><name><surname>Roberts</surname><given-names>AP</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>Zhong</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Tian</surname><given-names>GB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Involvement of transcription elongation factor grea in mycobacterium viability, antibiotic susceptibility, and intracellular fitness</article-title><source>Frontiers in Microbiology</source><volume>11</volume><elocation-id>413</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.00413</pub-id><pub-id pub-id-type="pmid">32265867</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkielsztein</surname><given-names>A</given-names></name><name><surname>Schlinker</surname><given-names>AC</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>WM</given-names></name><name><surname>Datta</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Human megakaryocyte progenitors derived from hematopoietic stem cells of normal individuals are MHC class II-expressing professional APC that enhance Th17 and Th1/Th17 responses</article-title><source>Immunology Letters</source><volume>163</volume><fpage>84</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2014.11.013</pub-id><pub-id pub-id-type="pmid">25454068</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuentes</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>YH</given-names></name><name><surname>Hirsch</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Rauova</surname><given-names>L</given-names></name><name><surname>Worthen</surname><given-names>GS</given-names></name><name><surname>Kowalska</surname><given-names>MA</given-names></name><name><surname>Poncz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Infusion of mature megakaryocytes into mice yields functional platelets</article-title><source>The Journal of Clinical Investigation</source><volume>120</volume><fpage>3917</fpage><lpage>3922</lpage><pub-id pub-id-type="doi">10.1172/JCI43326</pub-id><pub-id pub-id-type="pmid">20972336</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Göthert</surname><given-names>JR</given-names></name><name><surname>Gustin</surname><given-names>SE</given-names></name><name><surname>Hall</surname><given-names>MA</given-names></name><name><surname>Green</surname><given-names>AR</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Izon</surname><given-names>DJ</given-names></name><name><surname>Begley</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis</article-title><source>Blood</source><volume>105</volume><fpage>2724</fpage><lpage>2732</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-08-3037</pub-id><pub-id pub-id-type="pmid">15598809</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>S</given-names></name><name><surname>Hansson</surname><given-names>J</given-names></name><name><surname>Klimmeck</surname><given-names>D</given-names></name><name><surname>Loeffler</surname><given-names>D</given-names></name><name><surname>Velten</surname><given-names>L</given-names></name><name><surname>Uckelmann</surname><given-names>H</given-names></name><name><surname>Wurzer</surname><given-names>S</given-names></name><name><surname>Prendergast</surname><given-names>ÁM</given-names></name><name><surname>Schnell</surname><given-names>A</given-names></name><name><surname>Hexel</surname><given-names>K</given-names></name><name><surname>Santarella-Mellwig</surname><given-names>R</given-names></name><name><surname>Blaszkiewicz</surname><given-names>S</given-names></name><name><surname>Kuck</surname><given-names>A</given-names></name><name><surname>Geiger</surname><given-names>H</given-names></name><name><surname>Milsom</surname><given-names>MD</given-names></name><name><surname>Steinmetz</surname><given-names>LM</given-names></name><name><surname>Schroeder</surname><given-names>T</given-names></name><name><surname>Trumpp</surname><given-names>A</given-names></name><name><surname>Krijgsveld</surname><given-names>J</given-names></name><name><surname>Essers</surname><given-names>MAG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors</article-title><source>Cell Stem Cell</source><volume>17</volume><fpage>422</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.07.007</pub-id><pub-id pub-id-type="pmid">26299573</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname><given-names>T</given-names></name><name><surname>Möhle</surname><given-names>R</given-names></name><name><surname>Hesselgesser</surname><given-names>J</given-names></name><name><surname>Hoxie</surname><given-names>J</given-names></name><name><surname>Nachman</surname><given-names>RL</given-names></name><name><surname>Moore</surname><given-names>MA</given-names></name><name><surname>Rafii</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation</article-title><source>The Journal of Experimental Medicine</source><volume>188</volume><fpage>539</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1084/jem.188.3.539</pub-id><pub-id pub-id-type="pmid">9687531</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamey</surname><given-names>FK</given-names></name><name><surname>Lau</surname><given-names>WWY</given-names></name><name><surname>Kucinski</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Diamanti</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>NK</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Dahlin</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell molecular profiling provides a high-resolution map of basophil and mast cell development</article-title><source>Allergy</source><volume>76</volume><fpage>1731</fpage><lpage>1742</lpage><pub-id pub-id-type="doi">10.1111/all.14633</pub-id><pub-id pub-id-type="pmid">33078414</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hänzelmann</surname><given-names>S</given-names></name><name><surname>Castelo</surname><given-names>R</given-names></name><name><surname>Guinney</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>GSVA: gene set variation analysis for microarray and RNA-Seq data</article-title><source>BMC Bioinformatics</source><volume>14</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-14-7</pub-id><pub-id pub-id-type="pmid">23323831</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hérault</surname><given-names>A</given-names></name><name><surname>Binnewies</surname><given-names>M</given-names></name><name><surname>Leong</surname><given-names>S</given-names></name><name><surname>Calero-Nieto</surname><given-names>FJ</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><name><surname>Kang</surname><given-names>YA</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Pietras</surname><given-names>EM</given-names></name><name><surname>Chu</surname><given-names>SH</given-names></name><name><surname>Barry-Holson</surname><given-names>K</given-names></name><name><surname>Armstrong</surname><given-names>S</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Passegué</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis</article-title><source>Nature</source><volume>544</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1038/nature21693</pub-id><pub-id pub-id-type="pmid">28355185</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Matplotlib: a 2d graphics environment</article-title><source>Computing in Science &amp; Engineering</source><volume>9</volume><fpage>90</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1109/MCSE.2007.55</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itkin</surname><given-names>T</given-names></name><name><surname>Gur-Cohen</surname><given-names>S</given-names></name><name><surname>Spencer</surname><given-names>JA</given-names></name><name><surname>Schajnovitz</surname><given-names>A</given-names></name><name><surname>Ramasamy</surname><given-names>SK</given-names></name><name><surname>Kusumbe</surname><given-names>AP</given-names></name><name><surname>Ledergor</surname><given-names>G</given-names></name><name><surname>Jung</surname><given-names>Y</given-names></name><name><surname>Milo</surname><given-names>I</given-names></name><name><surname>Poulos</surname><given-names>MG</given-names></name><name><surname>Kalinkovich</surname><given-names>A</given-names></name><name><surname>Ludin</surname><given-names>A</given-names></name><name><surname>Golan</surname><given-names>K</given-names></name><name><surname>Khatib</surname><given-names>E</given-names></name><name><surname>Kumari</surname><given-names>A</given-names></name><name><surname>Kollet</surname><given-names>O</given-names></name><name><surname>Shakhar</surname><given-names>G</given-names></name><name><surname>Butler</surname><given-names>JM</given-names></name><name><surname>Rafii</surname><given-names>S</given-names></name><name><surname>Adams</surname><given-names>RH</given-names></name><name><surname>Scadden</surname><given-names>DT</given-names></name><name><surname>Lin</surname><given-names>CP</given-names></name><name><surname>Lapidot</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Distinct bone marrow blood vessels differentially regulate haematopoiesis</article-title><source>Nature</source><volume>532</volume><fpage>323</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1038/nature17624</pub-id><pub-id pub-id-type="pmid">27074509</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Phan</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Yeh</surname><given-names>ETH</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Kang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-β signaling</article-title><source>Journal of Experimental Medicine</source><volume>215</volume><fpage>1337</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1084/jem.20171477</pub-id><pub-id pub-id-type="pmid">29669741</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Guerrero-Juarez</surname><given-names>CF</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>I</given-names></name><name><surname>Ramos</surname><given-names>R</given-names></name><name><surname>Kuan</surname><given-names>CH</given-names></name><name><surname>Myung</surname><given-names>P</given-names></name><name><surname>Plikus</surname><given-names>MV</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Inference and analysis of cell-cell communication using CellChat</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1088</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21246-9</pub-id><pub-id pub-id-type="pmid">33597522</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanaji</surname><given-names>S</given-names></name><name><surname>Kanaji</surname><given-names>T</given-names></name><name><surname>Jacquelin</surname><given-names>B</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Nugent</surname><given-names>DJ</given-names></name><name><surname>Komatsu</surname><given-names>N</given-names></name><name><surname>Moroi</surname><given-names>M</given-names></name><name><surname>Izuhara</surname><given-names>K</given-names></name><name><surname>Kunicki</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation</article-title><source>Blood</source><volume>105</volume><fpage>3888</fpage><lpage>3892</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-08-3109</pub-id><pub-id pub-id-type="pmid">15701720</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>JB</given-names></name><name><surname>Nathan</surname><given-names>A</given-names></name><name><surname>Weinand</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Millard</surname><given-names>N</given-names></name><name><surname>Rumker</surname><given-names>L</given-names></name><name><surname>Moody</surname><given-names>DB</given-names></name><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Efficient and precise single-cell reference atlas mapping with Symphony</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>5890</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-25957-x</pub-id><pub-id pub-id-type="pmid">34620862</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karttunen</surname><given-names>J</given-names></name><name><surname>Sanderson</surname><given-names>S</given-names></name><name><surname>Shastri</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens</article-title><source>PNAS</source><volume>89</volume><fpage>6020</fpage><lpage>6024</lpage><pub-id pub-id-type="doi">10.1073/pnas.89.13.6020</pub-id><pub-id pub-id-type="pmid">1378619</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiselev</surname><given-names>VY</given-names></name><name><surname>Yiu</surname><given-names>A</given-names></name><name><surname>Hemberg</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>scmap: projection of single-cell RNA-seq data across data sets</article-title><source>Nature Methods</source><volume>15</volume><fpage>359</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4644</pub-id><pub-id pub-id-type="pmid">29608555</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhler</surname><given-names>A</given-names></name><name><surname>De Filippo</surname><given-names>K</given-names></name><name><surname>Hasenberg</surname><given-names>M</given-names></name><name><surname>van den Brandt</surname><given-names>C</given-names></name><name><surname>Nye</surname><given-names>E</given-names></name><name><surname>Hosking</surname><given-names>MP</given-names></name><name><surname>Lane</surname><given-names>TE</given-names></name><name><surname>Männ</surname><given-names>L</given-names></name><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Hauser</surname><given-names>AE</given-names></name><name><surname>Winter</surname><given-names>O</given-names></name><name><surname>Schraven</surname><given-names>B</given-names></name><name><surname>Geiger</surname><given-names>H</given-names></name><name><surname>Hogg</surname><given-names>N</given-names></name><name><surname>Gunzer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands</article-title><source>Blood</source><volume>117</volume><fpage>4349</fpage><lpage>4357</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-09-308387</pub-id><pub-id pub-id-type="pmid">21224471</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefrançais</surname><given-names>E</given-names></name><name><surname>Ortiz-Muñoz</surname><given-names>G</given-names></name><name><surname>Caudrillier</surname><given-names>A</given-names></name><name><surname>Mallavia</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Sayah</surname><given-names>DM</given-names></name><name><surname>Thornton</surname><given-names>EE</given-names></name><name><surname>Headley</surname><given-names>MB</given-names></name><name><surname>David</surname><given-names>T</given-names></name><name><surname>Coughlin</surname><given-names>SR</given-names></name><name><surname>Krummel</surname><given-names>MF</given-names></name><name><surname>Leavitt</surname><given-names>AD</given-names></name><name><surname>Passegué</surname><given-names>E</given-names></name><name><surname>Looney</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors</article-title><source>Nature</source><volume>544</volume><fpage>105</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1038/nature21706</pub-id><pub-id pub-id-type="pmid">28329764</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Jones</surname><given-names>LL</given-names></name><name><surname>Geiger</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>IL-6 promotes t cell proliferation and expansion under inflammatory conditions in association with low-level rorγt expression</article-title><source>Journal of Immunology</source><volume>201</volume><fpage>2934</fpage><lpage>2946</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1800016</pub-id><pub-id pub-id-type="pmid">30315140</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Xia</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Characterization of cellular heterogeneity and an immune subpopulation of human megakaryocytes</article-title><source>Advanced Science</source><volume>8</volume><elocation-id>e2100921</elocation-id><pub-id pub-id-type="doi">10.1002/advs.202100921</pub-id><pub-id pub-id-type="pmid">34042332</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machlus</surname><given-names>KR</given-names></name><name><surname>Italiano</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The incredible journey: From megakaryocyte development to platelet formation</article-title><source>The Journal of Cell Biology</source><volume>201</volume><fpage>785</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1083/jcb.201304054</pub-id><pub-id pub-id-type="pmid">23751492</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markovic</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Chesterman</surname><given-names>CN</given-names></name><name><surname>Chong</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Quantitation of soluble and membrane-bound Fc gamma RIIA (CD32A) mRNA in platelets and megakaryoblastic cell line (Meg-01)</article-title><source>British Journal of Haematology</source><volume>91</volume><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2141.1995.tb05241.x</pub-id><pub-id pub-id-type="pmid">7577649</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minutti</surname><given-names>CM</given-names></name><name><surname>Modak</surname><given-names>RV</given-names></name><name><surname>Macdonald</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>FQ</given-names></name><name><surname>Smyth</surname><given-names>DJ</given-names></name><name><surname>Dorward</surname><given-names>DA</given-names></name><name><surname>Blair</surname><given-names>N</given-names></name><name><surname>Husovsky</surname><given-names>C</given-names></name><name><surname>Muir</surname><given-names>A</given-names></name><name><surname>Giampazolias</surname><given-names>E</given-names></name><name><surname>Dobie</surname><given-names>R</given-names></name><name><surname>Maizels</surname><given-names>RM</given-names></name><name><surname>Kendall</surname><given-names>TJ</given-names></name><name><surname>Griggs</surname><given-names>DW</given-names></name><name><surname>Kopf</surname><given-names>M</given-names></name><name><surname>Henderson</surname><given-names>NC</given-names></name><name><surname>Zaiss</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A macrophage-pericyte axis directs tissue restoration via amphiregulin-induced transforming growth factor beta activation</article-title><source>Immunity</source><volume>50</volume><fpage>645</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.01.008</pub-id><pub-id pub-id-type="pmid">30770250</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>Y</given-names></name><name><surname>Muro</surname><given-names>Y</given-names></name><name><surname>Todokoro</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis</article-title><source>The Journal of Cell Biology</source><volume>139</volume><fpage>449</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1083/jcb.139.2.449</pub-id><pub-id pub-id-type="pmid">9334347</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>S</given-names></name><name><surname>Debili</surname><given-names>N</given-names></name><name><surname>Le Couedic</surname><given-names>JP</given-names></name><name><surname>Klein</surname><given-names>B</given-names></name><name><surname>Breton-Gorius</surname><given-names>J</given-names></name><name><surname>Doly</surname><given-names>J</given-names></name><name><surname>Vainchenker</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication</article-title><source>Blood</source><volume>77</volume><fpage>461</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">1991163</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negrotto</surname><given-names>S</given-names></name><name><surname>J De Giusti</surname><given-names>C</given-names></name><name><surname>Lapponi</surname><given-names>MJ</given-names></name><name><surname>Etulain</surname><given-names>J</given-names></name><name><surname>Rivadeneyra</surname><given-names>L</given-names></name><name><surname>Pozner</surname><given-names>RG</given-names></name><name><surname>Gomez</surname><given-names>RM</given-names></name><name><surname>Schattner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Expression and functionality of type I interferon receptor in the megakaryocytic lineage</article-title><source>Journal of Thrombosis and Haemostasis</source><volume>9</volume><fpage>2477</fpage><lpage>2485</lpage><pub-id pub-id-type="doi">10.1111/j.1538-7836.2011.04530.x</pub-id><pub-id pub-id-type="pmid">22136495</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>S</given-names></name><name><surname>Nagasaki</surname><given-names>M</given-names></name><name><surname>Kunishima</surname><given-names>S</given-names></name><name><surname>Sawaguchi</surname><given-names>A</given-names></name><name><surname>Sakata</surname><given-names>A</given-names></name><name><surname>Sakaguchi</surname><given-names>H</given-names></name><name><surname>Ohmori</surname><given-names>T</given-names></name><name><surname>Manabe</surname><given-names>I</given-names></name><name><surname>Italiano</surname><given-names>JE</given-names></name><name><surname>Ryu</surname><given-names>T</given-names></name><name><surname>Takayama</surname><given-names>N</given-names></name><name><surname>Komuro</surname><given-names>I</given-names></name><name><surname>Kadowaki</surname><given-names>T</given-names></name><name><surname>Eto</surname><given-names>K</given-names></name><name><surname>Nagai</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs</article-title><source>The Journal of Cell Biology</source><volume>209</volume><fpage>453</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1083/jcb.201410052</pub-id><pub-id pub-id-type="pmid">25963822</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>TS</given-names></name><name><surname>Caselli</surname><given-names>A</given-names></name><name><surname>Otsuru</surname><given-names>S</given-names></name><name><surname>Hofmann</surname><given-names>TJ</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name><name><surname>Paolucci</surname><given-names>P</given-names></name><name><surname>Dominici</surname><given-names>M</given-names></name><name><surname>Horwitz</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning</article-title><source>Blood</source><volume>121</volume><fpage>5238</fpage><lpage>5249</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-10-463414</pub-id><pub-id pub-id-type="pmid">23667055</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>Y</given-names></name><name><surname>Asazuma</surname><given-names>N</given-names></name><name><surname>Suzuki-Inoue</surname><given-names>K</given-names></name><name><surname>Berndt</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Platelet gpib-IX-V-dependent signaling</article-title><source>Journal of Thrombosis and Haemostasis</source><volume>3</volume><fpage>1745</fpage><lpage>1751</lpage><pub-id pub-id-type="doi">10.1111/j.1538-7836.2005.01379.x</pub-id><pub-id pub-id-type="pmid">16102041</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>K</given-names></name><name><surname>Nowak</surname><given-names>R</given-names></name><name><surname>Billington</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Sellers</surname><given-names>JR</given-names></name><name><surname>Fowler</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease</article-title><source>Blood</source><volume>135</volume><fpage>1887</fpage><lpage>1898</lpage><pub-id pub-id-type="doi">10.1182/blood.2019003064</pub-id><pub-id pub-id-type="pmid">32315395</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pariser</surname><given-names>DN</given-names></name><name><surname>Hilt</surname><given-names>ZT</given-names></name><name><surname>Ture</surname><given-names>SK</given-names></name><name><surname>Blick-Nitko</surname><given-names>SK</given-names></name><name><surname>Looney</surname><given-names>MR</given-names></name><name><surname>Cleary</surname><given-names>SJ</given-names></name><name><surname>Roman-Pagan</surname><given-names>E</given-names></name><name><surname>Saunders</surname><given-names>J</given-names></name><name><surname>Georas</surname><given-names>SN</given-names></name><name><surname>Veazey</surname><given-names>J</given-names></name><name><surname>Madere</surname><given-names>F</given-names></name><name><surname>Santos</surname><given-names>LT</given-names></name><name><surname>Arne</surname><given-names>A</given-names></name><name><surname>Huynh</surname><given-names>NP</given-names></name><name><surname>Livada</surname><given-names>AC</given-names></name><name><surname>Guerrero-Martin</surname><given-names>SM</given-names></name><name><surname>Lyons</surname><given-names>C</given-names></name><name><surname>Metcalf-Pate</surname><given-names>KA</given-names></name><name><surname>McGrath</surname><given-names>KE</given-names></name><name><surname>Palis</surname><given-names>J</given-names></name><name><surname>Morrell</surname><given-names>CN</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Lung megakaryocytes are immune modulatory cells</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>137377</elocation-id><pub-id pub-id-type="doi">10.1172/JCI137377</pub-id><pub-id pub-id-type="pmid">33079726</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>Hartwig</surname><given-names>JH</given-names></name><name><surname>Italiano</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The biogenesis of platelets from megakaryocyte proplatelets</article-title><source>The Journal of Clinical Investigation</source><volume>115</volume><fpage>3348</fpage><lpage>3354</lpage><pub-id pub-id-type="doi">10.1172/JCI26891</pub-id><pub-id pub-id-type="pmid">16322779</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>W</given-names></name><name><surname>Su</surname><given-names>B</given-names></name><name><surname>Cai</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Cao</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>G</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Gan</surname><given-names>R</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y-M</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Ling</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>S-Q</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Song</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Xing</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Zou</surname><given-names>B</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Bei</surname><given-names>J-X</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Bian</surname><given-names>X-W</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>F-S</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas</article-title><source>Cell</source><volume>184</volume><fpage>1895</fpage><lpage>1913</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.01.053</pub-id><pub-id pub-id-type="pmid">33657410</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Roney</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><chapter-title>Bone marrow-derived dendritic cells</chapter-title><person-group person-group-type="editor"><name><surname>Allen</surname><given-names>IC</given-names></name></person-group><source>Mouse Models of Innate Immunity: Methods and Protocols</source><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>57</fpage><lpage>62</lpage></element-citation></ref><ref id="bib60"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rothe</surname><given-names>G.</given-names></name><name><surname>Kellermann</surname><given-names>W.</given-names></name><name><surname>Briegel</surname><given-names>J.</given-names></name><name><surname>Schaerer</surname><given-names>B.</given-names></name><name><surname>Valet</surname><given-names>G.</given-names></name></person-group><year iso-8601-date="1993">1993</year><chapter-title>Activation of Neutrophils by Tumor Necrosis Factor-α During Sepsis</chapter-title><person-group person-group-type="editor"><name><surname>Faist</surname><given-names>E.</given-names></name><name><surname>Meakins</surname><given-names>J. L.</given-names></name><name><surname>Schildberg</surname><given-names>F. W.</given-names></name></person-group><source>Host Defense Dysfunction in Trauma, Shock and Sepsis: Mechanisms and Therapeutic Approaches</source><fpage>727</fpage><lpage>735</lpage><publisher-name>Springer</publisher-name><publisher-loc>Berlin Heidelberg</publisher-loc></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saçma</surname><given-names>M</given-names></name><name><surname>Pospiech</surname><given-names>J</given-names></name><name><surname>Bogeska</surname><given-names>R</given-names></name><name><surname>de Back</surname><given-names>W</given-names></name><name><surname>Mallm</surname><given-names>J-P</given-names></name><name><surname>Sakk</surname><given-names>V</given-names></name><name><surname>Soller</surname><given-names>K</given-names></name><name><surname>Marka</surname><given-names>G</given-names></name><name><surname>Vollmer</surname><given-names>A</given-names></name><name><surname>Karns</surname><given-names>R</given-names></name><name><surname>Cabezas-Wallscheid</surname><given-names>N</given-names></name><name><surname>Trumpp</surname><given-names>A</given-names></name><name><surname>Méndez-Ferrer</surname><given-names>S</given-names></name><name><surname>Milsom</surname><given-names>MD</given-names></name><name><surname>Mulaw</surname><given-names>MA</given-names></name><name><surname>Geiger</surname><given-names>H</given-names></name><name><surname>Florian</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Haematopoietic stem cells in perisinusoidal niches are protected from ageing</article-title><source>Nature Cell Biology</source><volume>21</volume><fpage>1309</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0418-y</pub-id><pub-id pub-id-type="pmid">31685996</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>JW</given-names></name><name><surname>Italiano</surname><given-names>JE</given-names></name><name><surname>Freedman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Platelets and the immune continuum</article-title><source>Nature Reviews. Immunology</source><volume>11</volume><fpage>264</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1038/nri2956</pub-id><pub-id pub-id-type="pmid">21436837</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapouri-Moghaddam</surname><given-names>A</given-names></name><name><surname>Mohammadian</surname><given-names>S</given-names></name><name><surname>Vazini</surname><given-names>H</given-names></name><name><surname>Taghadosi</surname><given-names>M</given-names></name><name><surname>Esmaeili</surname><given-names>SA</given-names></name><name><surname>Mardani</surname><given-names>F</given-names></name><name><surname>Seifi</surname><given-names>B</given-names></name><name><surname>Mohammadi</surname><given-names>A</given-names></name><name><surname>Afshari</surname><given-names>JT</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Macrophage plasticity, polarization, and function in health and disease</article-title><source>Journal of Cellular Physiology</source><volume>233</volume><fpage>6425</fpage><lpage>6440</lpage><pub-id pub-id-type="doi">10.1002/jcp.26429</pub-id><pub-id pub-id-type="pmid">29319160</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharif</surname><given-names>O</given-names></name><name><surname>Gawish</surname><given-names>R</given-names></name><name><surname>Warszawska</surname><given-names>JM</given-names></name><name><surname>Martins</surname><given-names>R</given-names></name><name><surname>Lakovits</surname><given-names>K</given-names></name><name><surname>Hladik</surname><given-names>A</given-names></name><name><surname>Doninger</surname><given-names>B</given-names></name><name><surname>Brunner</surname><given-names>J</given-names></name><name><surname>Korosec</surname><given-names>A</given-names></name><name><surname>Schwarzenbacher</surname><given-names>RE</given-names></name><name><surname>Berg</surname><given-names>T</given-names></name><name><surname>Kralovics</surname><given-names>R</given-names></name><name><surname>Colinge</surname><given-names>J</given-names></name><name><surname>Mesteri</surname><given-names>I</given-names></name><name><surname>Gilfillan</surname><given-names>S</given-names></name><name><surname>Salmaggi</surname><given-names>A</given-names></name><name><surname>Verschoor</surname><given-names>A</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Knapp</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1004167</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004167</pub-id><pub-id pub-id-type="pmid">24945405</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname><given-names>E</given-names></name><name><surname>Reynolds</surname><given-names>G</given-names></name><name><surname>Botting</surname><given-names>RA</given-names></name><name><surname>Calero-Nieto</surname><given-names>FJ</given-names></name><name><surname>Morgan</surname><given-names>MD</given-names></name><name><surname>Tuong</surname><given-names>ZK</given-names></name><name><surname>Bach</surname><given-names>K</given-names></name><name><surname>Sungnak</surname><given-names>W</given-names></name><name><surname>Worlock</surname><given-names>KB</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Kumasaka</surname><given-names>N</given-names></name><name><surname>Kania</surname><given-names>K</given-names></name><name><surname>Engelbert</surname><given-names>J</given-names></name><name><surname>Olabi</surname><given-names>B</given-names></name><name><surname>Spegarova</surname><given-names>JS</given-names></name><name><surname>Wilson</surname><given-names>NK</given-names></name><name><surname>Mende</surname><given-names>N</given-names></name><name><surname>Jardine</surname><given-names>L</given-names></name><name><surname>Gardner</surname><given-names>LCS</given-names></name><name><surname>Goh</surname><given-names>I</given-names></name><name><surname>Horsfall</surname><given-names>D</given-names></name><name><surname>McGrath</surname><given-names>J</given-names></name><name><surname>Webb</surname><given-names>S</given-names></name><name><surname>Mather</surname><given-names>MW</given-names></name><name><surname>Lindeboom</surname><given-names>RGH</given-names></name><name><surname>Dann</surname><given-names>E</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Polanski</surname><given-names>K</given-names></name><name><surname>Prigmore</surname><given-names>E</given-names></name><name><surname>Gothe</surname><given-names>F</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Payne</surname><given-names>RP</given-names></name><name><surname>Baker</surname><given-names>KF</given-names></name><name><surname>Hanrath</surname><given-names>AT</given-names></name><name><surname>Schim van der Loeff</surname><given-names>ICD</given-names></name><name><surname>Barr</surname><given-names>AS</given-names></name><name><surname>Sanchez-Gonzalez</surname><given-names>A</given-names></name><name><surname>Bergamaschi</surname><given-names>L</given-names></name><name><surname>Mescia</surname><given-names>F</given-names></name><name><surname>Barnes</surname><given-names>JL</given-names></name><name><surname>Kilich</surname><given-names>E</given-names></name><name><surname>de Wilton</surname><given-names>A</given-names></name><name><surname>Saigal</surname><given-names>A</given-names></name><name><surname>Saleh</surname><given-names>A</given-names></name><name><surname>Janes</surname><given-names>SM</given-names></name><name><surname>Smith</surname><given-names>CM</given-names></name><name><surname>Gopee</surname><given-names>N</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Coupland</surname><given-names>P</given-names></name><name><surname>Coxhead</surname><given-names>JM</given-names></name><name><surname>Kiselev</surname><given-names>VY</given-names></name><name><surname>van Dongen</surname><given-names>S</given-names></name><name><surname>Bacardit</surname><given-names>J</given-names></name><name><surname>King</surname><given-names>HW</given-names></name><name><surname>Rostron</surname><given-names>AJ</given-names></name><name><surname>Simpson</surname><given-names>AJ</given-names></name><name><surname>Hambleton</surname><given-names>S</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name><name><surname>Nikolić</surname><given-names>MZ</given-names></name><name><surname>Duncan</surname><given-names>CJA</given-names></name><name><surname>Smith</surname><given-names>KGC</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Clatworthy</surname><given-names>MR</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name><collab>Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research COVID-19 BioResource Collaboration</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell multi-omics analysis of the immune response in COVID-19</article-title><source>Nature Medicine</source><volume>27</volume><fpage>904</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01329-2</pub-id><pub-id pub-id-type="pmid">33879890</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Kohara</surname><given-names>H</given-names></name><name><surname>Noda</surname><given-names>M</given-names></name><name><surname>Nagasawa</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches</article-title><source>Immunity</source><volume>25</volume><fpage>977</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.10.016</pub-id><pub-id pub-id-type="pmid">17174120</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>C</given-names></name><name><surname>Si</surname><given-names>J</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Rondina</surname><given-names>MT</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>QF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell analysis of ploidy and the transcriptome reveals functional and spatial divergency in murine megakaryopoiesis</article-title><source>Blood</source><volume>138</volume><fpage>1211</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1182/blood.2021010697</pub-id><pub-id pub-id-type="pmid">34115843</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suraneni</surname><given-names>PK</given-names></name><name><surname>Corey</surname><given-names>SJ</given-names></name><name><surname>Hession</surname><given-names>MJ</given-names></name><name><surname>Ishaq</surname><given-names>R</given-names></name><name><surname>Awomolo</surname><given-names>A</given-names></name><name><surname>Hasan</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Wickrema</surname><given-names>A</given-names></name><name><surname>Debili</surname><given-names>N</given-names></name><name><surname>Crispino</surname><given-names>JD</given-names></name><name><surname>Eklund</surname><given-names>EA</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity</article-title><source>Blood Advances</source><volume>2</volume><fpage>3540</fpage><lpage>3552</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2018021923</pub-id><pub-id pub-id-type="pmid">30538113</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>S</given-names></name><name><surname>Suzuki-Inoue</surname><given-names>K</given-names></name><name><surname>Tsukiji</surname><given-names>N</given-names></name><name><surname>Shirai</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Osada</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>K</given-names></name><name><surname>Ozaki</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2</article-title><source>Blood</source><volume>127</volume><fpage>1701</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1182/blood-2015-08-663708</pub-id><pub-id pub-id-type="pmid">26796360</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiedt</surname><given-names>R</given-names></name><name><surname>Schomber</surname><given-names>T</given-names></name><name><surname>Hao-Shen</surname><given-names>H</given-names></name><name><surname>Skoda</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo</article-title><source>Blood</source><volume>109</volume><fpage>1503</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-04-020362</pub-id><pub-id pub-id-type="pmid">17032923</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verschoor</surname><given-names>A</given-names></name><name><surname>Neuenhahn</surname><given-names>M</given-names></name><name><surname>Navarini</surname><given-names>AA</given-names></name><name><surname>Graef</surname><given-names>P</given-names></name><name><surname>Plaumann</surname><given-names>A</given-names></name><name><surname>Seidlmeier</surname><given-names>A</given-names></name><name><surname>Nieswandt</surname><given-names>B</given-names></name><name><surname>Massberg</surname><given-names>S</given-names></name><name><surname>Zinkernagel</surname><given-names>RM</given-names></name><name><surname>Hengartner</surname><given-names>H</given-names></name><name><surname>Busch</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3</article-title><source>Nature Immunology</source><volume>12</volume><fpage>1194</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1038/ni.2140</pub-id><pub-id pub-id-type="pmid">22037602</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JF</given-names></name><name><surname>Liu</surname><given-names>ZY</given-names></name><name><surname>Groopman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion</article-title><source>Blood</source><volume>92</volume><fpage>756</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">9680341</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Bai</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>P</given-names></name><name><surname>Xia</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Bian</surname><given-names>L</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Decoding human megakaryocyte development</article-title><source>Cell Stem Cell</source><volume>28</volume><fpage>535</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.11.006</pub-id><pub-id pub-id-type="pmid">33340451</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Hou</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>IMAP: integration of multiple single-cell datasets by adversarial paired transfer networks</article-title><source>Genome Biology</source><volume>22</volume><elocation-id>63</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-021-02280-8</pub-id><pub-id pub-id-type="pmid">33602306</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>JR</given-names></name><name><surname>Bingle</surname><given-names>L</given-names></name><name><surname>Judge</surname><given-names>HM</given-names></name><name><surname>Brown</surname><given-names>SB</given-names></name><name><surname>Storey</surname><given-names>RF</given-names></name><name><surname>Whyte</surname><given-names>MKB</given-names></name><name><surname>Dower</surname><given-names>SK</given-names></name><name><surname>Buttle</surname><given-names>DJ</given-names></name><name><surname>Sabroe</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor</article-title><source>Thrombosis and Haemostasis</source><volume>94</volume><fpage>831</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">16270639</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>T</given-names></name><name><surname>Wiegraebe</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>XC</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Stark</surname><given-names>D</given-names></name><name><surname>Perko</surname><given-names>K</given-names></name><name><surname>Alexander</surname><given-names>R</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Grindley</surname><given-names>JC</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Haug</surname><given-names>JS</given-names></name><name><surname>Wunderlich</surname><given-names>JP</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Feldman</surname><given-names>RA</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Detection of functional haematopoietic stem cell niche using real-time imaging</article-title><source>Nature</source><volume>457</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1038/nature07639</pub-id><pub-id pub-id-type="pmid">19052548</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Kambara</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Guo</surname><given-names>R</given-names></name><name><surname>Ren</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Silberstein</surname><given-names>LE</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Luo</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection</article-title><source>Nature Immunology</source><volume>21</volume><fpage>1119</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0736-z</pub-id><pub-id pub-id-type="pmid">32719519</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>S</given-names></name><name><surname>Ema</surname><given-names>H</given-names></name><name><surname>Karlsson</surname><given-names>G</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Miyoshi</surname><given-names>H</given-names></name><name><surname>Shioda</surname><given-names>S</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Karlsson</surname><given-names>S</given-names></name><name><surname>Iwama</surname><given-names>A</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche</article-title><source>Cell</source><volume>147</volume><fpage>1146</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.09.053</pub-id><pub-id pub-id-type="pmid">22118468</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Chui</surname><given-names>CM</given-names></name><name><surname>Yuen</surname><given-names>PM</given-names></name><name><surname>Chan</surname><given-names>PK</given-names></name><name><surname>Chuen</surname><given-names>CK</given-names></name><name><surname>Li</surname><given-names>CK</given-names></name><name><surname>Fok</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression</article-title><source>British Journal of Haematology</source><volume>111</volume><fpage>371</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2141.2000.02340.x</pub-id><pub-id pub-id-type="pmid">11091227</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>AK</given-names></name><name><surname>Villacorta-Martin</surname><given-names>C</given-names></name><name><surname>Hon</surname><given-names>S</given-names></name><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Murphy</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lung megakaryocytes display distinct transcriptional and phenotypic properties</article-title><source>Blood Advances</source><volume>4</volume><fpage>6204</fpage><lpage>6217</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2020002843</pub-id><pub-id pub-id-type="pmid">33351116</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>Omics: A Journal of Integrative Biology</source><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>enrichplot: Visualization of Functional Enrichment Result</data-title><source>Enrichplot</source><ext-link ext-link-type="uri" xlink:href="https://github.com/GuangchuangYu/enrichplot">https://github.com/GuangchuangYu/enrichplot</ext-link></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Perry</surname><given-names>JM</given-names></name><name><surname>Marshall</surname><given-names>H</given-names></name><name><surname>Venkatraman</surname><given-names>A</given-names></name><name><surname>Qian</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>XC</given-names></name><name><surname>Ahamed</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells</article-title><source>Nature Medicine</source><volume>20</volume><fpage>1321</fpage><lpage>1326</lpage><pub-id pub-id-type="doi">10.1038/nm.3706</pub-id><pub-id pub-id-type="pmid">25326798</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zufferey</surname><given-names>A</given-names></name><name><surname>Speck</surname><given-names>ER</given-names></name><name><surname>Machlus</surname><given-names>KR</given-names></name><name><surname>Aslam</surname><given-names>R</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>McVey</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Kapur</surname><given-names>R</given-names></name><name><surname>Boilard</surname><given-names>E</given-names></name><name><surname>Italiano</surname><given-names>JE</given-names></name><name><surname>Semple</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets</article-title><source>Blood Advances</source><volume>1</volume><fpage>1773</fpage><lpage>1785</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2017007021</pub-id><pub-id pub-id-type="pmid">29296823</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78662.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rehman</surname><given-names>Jalees</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02mpq6x41</institution-id><institution>University of Illinois at Chicago</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.06.09.447810" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.06.09.447810"/></front-stub><body><p>The manuscript by Wang and colleagues studies the heterogeneity of megakaryocytes using single-cell RNA-seq and identifies a subpopulation of CXCR4-high megakaryocytes with immune modulatory roles. Functional studies in this paper show that this subpopulation of megakaryocytes promotes bacterial phagocytosis by macrophages and neutrophils. The compelling evidence for these findings in the manuscript and the fundamental significance of identifying mechanisms by which megakaryocyte subpopulations can impact host defense make this work of interest to researchers in the fields of immunology, hematopoiesis and megakaryocyte biology.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78662.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rehman</surname><given-names>Jalees</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02mpq6x41</institution-id><institution>University of Illinois at Chicago</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Rehman</surname><given-names>Jalees</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02mpq6x41</institution-id><institution>University of Illinois at Chicago</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.06.09.447810">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.06.09.447810v2">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Megakaryocyte derived immune-stimulating cells regulate host-defense immunity against bacterial pathogens&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Jalees Rehman as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Jos van der Meer as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. Please clarify whether these are Megakaryocyte-derived immune cells (MDICs) or simply a subpopulation of megakaryocytes (MK5). The presented data does not provide any evidence for the &quot;derivation&quot; process such as differentiation factors that convert the megakaryocyte subpopulation MK5 into a different &quot;immune cell&quot;. Therefore, it is requested to change the MDIC term and instead use an expression that indicates that these cells are a subset of megakaryocytes.</p><p>2. Please perform studies to ascertain the phagocytosis potential of this megakaryocyte subset. Are they capable of direct bacterial phagocytosis in the absence of other immune cells or do they only enhance bacterial phagocytosis by other immune cells?</p><p>3. Does this CXCR4 high megakaryocyte subset overlap with other megakaryocyte subsets demonstrating immune cell functions that have been recently reported such as antigen processing or antigen presentation? Assessing their antigen processing or antigen presentation capacity would help define the roles of this MK subset in host defense.</p><p>4. Does the CXCR4 high megakaryocyte subset also generate platelets or is their platelet generation function diminished compared to other megakaryocyte subsets, thus indicating that they are more specialized for immune functions.</p><p>5. How is this CXCR4 subset generated and what is their fate after infusion? Does CXCR4 get upregulated during infection on non-CXCR4 megakaryocytes? This would suggest that they are not terminally programmed to be CXCR4 high but that other megakaryocyte subsets can become MK5/CXCR4 high and take on such host defense functions.</p><p>6. Conclusions and generalizations need to be adjusted based on the comments of the reviewers as provided below. One specific example is the need to moderate claims about the role of megakaryocytes in adaptive immunity as this was not addressed in depth. Other examples of conclusions that need to be moderated are also listed by the reviewers in their specific comments.</p><p>7. Some technical details need to be addressed such as clarifying flow cytometry gating strategies or describing the new imaging approach. Description of the imaging approach and objective quantification of imaging data is essential to increase the robustness of the conclusions. The goal is for readers to be able to understand and replicate the experiments. More protein level quantifications of cytokines using flow cytometry or ELISA are also required to justify several of the conclusions.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Specific suggestions to include in the manuscript would include:</p><p>1. Perform antigen processing assays with CXCR4 high and CXCR4 low MKs to then assess whether this is the subset that drives the adaptive immune modulatory function</p><p>2. Use CXCR4 low cells and expose them ex vivo to inflammatory or infectious stimuli to assess whether they can become CXCR4 high. This would assess the plasticity of the MK subsets.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Previous studies suggested that immune MKs are capable of phagocytosis themselves and not just supporting immune cells. Are MDIC cells capable of direct bacterial phagocytosis?</p><p>In Figure 2, it's unclear if the myeloid cell-CXCR4high MK association is simply a result of the expansion of myeloid cells upon infection. Is this association observed in homeostasis?</p><p>What happens to CXCR4 expression on MKs upon infection? It would be important to understand if CXCR4low MKs are &quot;reprogrammed&quot; into CXCR4high MKs upon infection.</p><p>Other technical concerns:</p><p>– Elisa or flow cytometry analyses would be more accurate to evaluate TNFα, IL-6, and CXCL12 levels.</p><p>– The authors describe a new method of &quot;bone marrow live imaging&quot;, however it's unclear how imaging of flushed bone marrow plugs ex vivo accurately reflects live imaging.</p><p>– It's unclear the gating strategy used to quantify bone marrow, liver and spleen myeloid cell populations in Figure 3 as some of these populations rely on tissue specific markers.</p><p>– In Figure 4 supplemental 3, it's unusual to present CXCL12 levels as mRNA expression from total cells in the tissue, and it's even more surprising that the authors can detect accurate levels in organs such as the bone marrow or spleen since only small subsets of cells express CXCL12 in the tissue.</p><p>– Small concern, in Figure 4G the results are presented in different formats alternating between absolute number quantification or percentages.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>There are a number of specific things the authors can do to improve this manuscript.</p><p>1. The term MDIC should be reconsidered – especially the meaning of the D – are they Mk derived, or a subset of Mks? Since seem to be a subset, the derived is not really appropriate.</p><p>2. The authors indicate that the MDIC enhance the phagocytosis capacity of other cells – but do they also phagocytose bacteria? Is this contact dependent or independent to better show is a secreted product or not.</p><p>3. The DT model ablates both Mks and platelets. Therefore many of the changes in bacteria and immune cells could be platelet driven, not Mk or MDIC driven. This must be reconciled or the conclusions drastically restated in Figure 3.</p><p>4. Where do the infused MDIC go? Marrow, spleen, lung or all of the above? Do they make platelets and if so better or worse than Mk1 or Mk2 populations?</p><p>5. Do any of the lung migrated Mk become extravascular lung Mks, as 2/3 of lung Mks are extravascular? Or do they stay intravascular platelet producing Mks?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78662.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions (for the authors):</p><p>1. Please clarify whether these are Megakaryocyte-derived immune cells (MDICs) or simply a subpopulation of megakaryocytes (MK5). The presented data does not provide any evidence for the &quot;derivation&quot; process such as differentiation factors that convert the megakaryocyte subpopulation MK5 into a different &quot;immune cell&quot;. Therefore, it is requested to change the MDIC term and instead use an expression that indicates that these cells are a subset of megakaryocytes.</p></disp-quote><p>Thanks for the suggestion. We have changed the MDICs term to CXCR4<sup>high</sup> MKs.</p><disp-quote content-type="editor-comment"><p>2. Please perform studies to ascertain the phagocytosis potential of this megakaryocyte subset. Are they capable of direct bacterial phagocytosis in the absence of other immune cells or do they only enhance bacterial phagocytosis by other immune cells?</p></disp-quote><p>Our revised data showed that CXCR4<sup>high</sup> MKs were capable of bacterial phagocytosis (Revised Figure 3F).</p><disp-quote content-type="editor-comment"><p>3. Does this CXCR4 high megakaryocyte subset overlap with other megakaryocyte subsets demonstrating immune cell functions that have been recently reported such as antigen processing or antigen presentation? Assessing their antigen processing or antigen presentation capacity would help define the roles of this MK subset in host defense.</p></disp-quote><p>Our revised data showed that CXCR4<sup>high</sup> MKs were able to phagocytose bacteria (Revised Figure 3F), and process and present ovalbumin (OVA) antigens on their cell surface (Revised Figure 3G) to activate CD8<sup>+</sup> OT-I T cells (Revised Figure 3H) and B3Z T cells (Revised Figure 3-S2), a T cell hybridoma which expresses TCR that specifically recognizes OVA. These revised data showed that CXCR4<sup>high</sup> MKs had antigen processing and antigen presentation capacity.</p><disp-quote content-type="editor-comment"><p>4. Does the CXCR4 high megakaryocyte subset also generate platelets or is their platelet generation function diminished compared to other megakaryocyte subsets, thus indicating that they are more specialized for immune functions.</p></disp-quote><p>Our revised data showed that CXCR4<sup>high</sup> MKs also generated platelets but with lower efficiency compared to CXCR4<sup>low</sup> MKs (Revised Figure 1-S6D), suggesting CXCR4<sup>high</sup> MKs might be specialized for immune functions.</p><disp-quote content-type="editor-comment"><p>5. How is this CXCR4 subset generated and what is their fate after infusion? Does CXCR4 get upregulated during infection on non-CXCR4 megakaryocytes? This would suggest that they are not terminally programmed to be CXCR4 high but that other megakaryocyte subsets can become MK5/CXCR4 high and take on such host defense functions.</p></disp-quote><p>Our revised data showed that inflammatory treatment, including interferon γ, LPS, and <italic>L. monocytogenes</italic> could not increase CXCR4 expression in CXCR4<sup>low</sup> MKs (Revised Figure 4H and Figure 4-S4D). This experiment suggested that CXCR4<sup>high</sup> MKs might not be reprogramed from CXCR4<sup>low</sup> MKs. Furthermore, our HSPC tracing experiment showed that CXCR4<sup>high</sup> MKs were generated from HSPCs as efficiently as CXCR4<sup>low</sup> MKs during the acute inflammation-induced emergency megakaryopoiesis (Revised Figure 5E-G).</p><disp-quote content-type="editor-comment"><p>6. Conclusions and generalizations need to be adjusted based on the comments of the reviewers as provided below. One specific example is the need to moderate claims about the role of megakaryocytes in adaptive immunity as this was not addressed in depth. Other examples of conclusions that need to be moderated are also listed by the reviewers in their specific comments.</p></disp-quote><p>We have removed the conclusion about adaptive immunity as suggested.</p><disp-quote content-type="editor-comment"><p>7. Some technical details need to be addressed such as clarifying flow cytometry gating strategies or describing the new imaging approach. Description of the imaging approach and objective quantification of imaging data is essential to increase the robustness of the conclusions. The goal is for readers to be able to understand and replicate the experiments. More protein level quantifications of cytokines using flow cytometry or ELISA are also required to justify several of the conclusions.</p></disp-quote><p>In this revision, we have added flow cytometry gating strategies (Revised Figure 3-S1C, E, F and Figure 4-S4G, H), and the description for the ex vivo live imaging approach in the method section (Line 7-18, Page 26). We have also performed flow cytometry assays to confirm the imaging assays for bacterial phagocytosis assays, quantification of MKs and cytokine expression (Revised Figure 2J, M, N, Figure 2-S2A, B, Figure 4I, O and Figure 4-S4I).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>Specific suggestions to include in the manuscript would include:</p><p>1. Perform antigen processing assays with CXCR4 high and CXCR4 low MKs to then assess whether this is the subset that drives the adaptive immune modulatory function</p></disp-quote><p>Thanks for the suggested experiment. Our revised data showed that CXCR4<sup>high</sup> MKs, but not CXCR4<sup>low</sup> MKs, were able to process and present ovalbumin (OVA) antigens on their cell surface (Revised Figure 3G) and activate T cells (Revised Figure 3H and Figure 3-S2).</p><disp-quote content-type="editor-comment"><p>2. Use CXCR4 low cells and expose them ex vivo to inflammatory or infectious stimuli to assess whether they can become CXCR4 high. This would assess the plasticity of the MK subsets.</p></disp-quote><p>Our revised data showed that inflammatory treatment, including interferon γ, LPS, and <italic>L. monocytogenes</italic> could not increase CXCR4 expression in CXCR4<sup>low</sup> MKs (Revised Figure 4H and Figure 4-S4D). This experiment suggested that CXCR4<sup>high</sup> MKs might not be reprogramed from CXCR4<sup>low</sup> MKs, although we cannot entirely exclude the plasticity of MK subsets. We have included a brief discussion in the current version (Line 20-22, Page14).</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Previous studies suggested that immune MKs are capable of phagocytosis themselves and not just supporting immune cells. Are MDIC cells capable of direct bacterial phagocytosis?</p></disp-quote><p>Our revised data showed that MDICs (now referred to as CXCR4<sup>high</sup> MKs) were capable of phagocytosis for bacteria (Revised Figure 3F).</p><disp-quote content-type="editor-comment"><p>In Figure 2, it's unclear if the myeloid cell-CXCR4high MK association is simply a result of the expansion of myeloid cells upon infection. Is this association observed in homeostasis?</p></disp-quote><p>In this revision, we showed that CXCR4<sup>high</sup> MKs were significantly associated with myeloid cells upon infection compared with randomly distributed spots in the mathematical modeling (Revised Figure 2B-C). This may not be due to the expansion of myeloid cells, as the association between CXCR4<sup>low</sup> MKs and myeloid cells was not significant compared to randomly distributed spots (Revised Figure 2C). Furthermore, we did not observe the association between CXCR4<sup>high</sup> MKs and myeloid cells during homeostasis (Revised Figure 2-S1C, D).</p><disp-quote content-type="editor-comment"><p>What happens to CXCR4 expression on MKs upon infection? It would be important to understand if CXCR4low MKs are &quot;reprogrammed&quot; into CXCR4high MKs upon infection.</p></disp-quote><p>Thanks for the suggested experiment. Our revised data showed that inflammatory treatment, including Interferon γ, LPS, and <italic>L. monocytogenes</italic> could not increase CXCR4 expression in CXCR4<sup>low</sup> MKs (Revised Figure 4H and Figure 4-S4D). This experiment suggested that CXCR4<sup>high</sup> MKs might not be reprogramed from CXCR4<sup>low</sup> MKs, although we cannot entirely exclude the plasticity of MK subsets. We have included a brief discussion in the current version (Line 20-22, Page 14).</p><disp-quote content-type="editor-comment"><p>Other technical concerns:</p><p>– Elisa or flow cytometry analyses would be more accurate to evaluate TNFα, IL-6, and CXCL12 levels.</p></disp-quote><p>Thanks for the suggested experiments. In this revision, we have further evaluated the expression of TNFα and IL-6 by flow cytometry, which consistently showed that CXCR4<sup>high</sup> MKs had higher expression levels of TNFα and IL-6 than CXCR4<sup>low</sup> MKs (Revised Figure 2J). We have also adapted <italic>Cxcl12<sup>DsRed</sup></italic> reporter mouse line to show that CXCL12 was upregulated in the liver and spleen but reduced in bone marrow upon infection by flow cytometry assays (Revised Figure 4-S3E-H)<italic>.</italic></p><disp-quote content-type="editor-comment"><p>– The authors describe a new method of &quot;bone marrow live imaging&quot;, however it's unclear how imaging of flushed bone marrow plugs ex vivo accurately reflects live imaging.</p></disp-quote><p>Sorry for the inaccurate description. This an ex vivo imaging approach, which is developed before for the real-time imaging in the bone (Xie et al., Nature 2009). We have described this ex vivo imaging approach in the result and method section (Line 7-18, Page 26).</p><disp-quote content-type="editor-comment"><p>– It's unclear the gating strategy used to quantify bone marrow, liver and spleen myeloid cell populations in Figure 3 as some of these populations rely on tissue specific markers.</p></disp-quote><p>Thanks for pointing out this technical issue. To avoid inconsistency, we analyzed the CD11b<sup>+</sup> Ly6c<sup>+</sup> monocytes, CD11b<sup>+</sup>F4/80<sup>+</sup>Ly6c<sup>–</sup> macrophages, CD11c<sup>+</sup>CD11b<sup>+</sup> dendritic cells, and CD11b<sup>+</sup>Ly6c<sup>–</sup>Gr-1<sup>+</sup> neutrophils from bone marrow, liver, and spleen. The gating strategy has been used in previous studies (Krenkel et al., Gut 2020; Swirski et al., Science 2009). We have also included the representative gating strategies for myeloid cells (Revised Figure 3-S1C, E, F).</p><disp-quote content-type="editor-comment"><p>– In Figure 4 supplemental 3, it's unusual to present CXCL12 levels as mRNA expression from total cells in the tissue, and it's even more surprising that the authors can detect accurate levels in organs such as the bone marrow or spleen since only small subsets of cells express CXCL12 in the tissue.</p></disp-quote><p>We agree with this argument. In this revision, we employed a <italic>Cxcl12<sup>DsRed</sup></italic> reporter mouse line, and further confirmed that CXCL12 was upregulated in the liver and spleen but reduced in bone marrow upon infection (Revised Figure 4-S3E-H).</p><disp-quote content-type="editor-comment"><p>– Small concern, in Figure 4G the results are presented in different formats alternating between absolute number quantification or percentages.</p></disp-quote><p>Thanks for the suggestion. We presented these results in percentage in the current version (Revised Figure 4G).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>There are a number of specific things the authors can do to improve this manuscript.</p><p>1. The term MDIC should be reconsidered – especially the meaning of the D – are they Mk derived, or a subset of Mks? Since seem to be a subset, the derived is not really appropriate.</p></disp-quote><p>We agree with this argument. We have changed the MDIC term to CXCR4<sup>high</sup> MKs in the current version as suggested.</p><disp-quote content-type="editor-comment"><p>2. The authors indicate that the MDIC enhance the phagocytosis capacity of other cells – but do they also phagocytose bacteria? Is this contact dependent or independent to better show is a secreted product or not.</p></disp-quote><p>Thanks for pointing out this issue. Our revised data showed that CXCR4<sup>high</sup> MKs were capable of bacterial phagocytosis, although the efficiency was relatively lower compared to neutrophils (Revised Figure 3F). Furthermore, CXCR4<sup>high</sup> MKs promoted the phagocytosis capacity of neutrophils and macrophages in the upper inserts of transwell plates (Revised Figure 2E-H and Figure 2-S2A, B), which indicated that CXCR4<sup>high</sup> MKs promote the phagocytosis capacity of other cells through a cell-contact independent manner. By using neutralizing antibodies, we also showed that CXCR4<sup>high</sup> MKs promote the phagocytosis of immune cells partially through secreting IL-6 and TNFα (Revised Figure 2K-N).</p><disp-quote content-type="editor-comment"><p>3. The DT model ablates both Mks and platelets. Therefore many of the changes in bacteria and immune cells could be platelet driven, not Mk or MDIC driven. This must be reconciled or the conclusions drastically restated in Figure 3.</p></disp-quote><p>We agree with this argument. Our infusion rescue with CXCR4<sup>high</sup> MKs did not fully rescue the host-defense responses in MK ablated mice, which might be partially due to the reduced platelets, which are known for immune responses. We have discussed this possibility in the current version (Line 16-17, Page 9).</p><disp-quote content-type="editor-comment"><p>4. Where do the infused MDIC go? Marrow, spleen, lung or all of the above? Do they make platelets and if so better or worse than Mk1 or Mk2 populations?</p></disp-quote><p>The infused MDICs (now referred to as CXCR4<sup>high</sup> MKs) preferably migrated to the liver and spleen; conversely, the infused CXCR4<sup>low</sup> MKs preferably migrated to the bone marrow (Revised Figure 4J-O). Furthermore, CXCR4<sup>high</sup> MKs produced fewer platelets than CXCR4<sup>low</sup> MKs, which enriched MK1 and MK2 populations (Revised Figure 1-S6D).</p><disp-quote content-type="editor-comment"><p>5. Do any of the lung migrated Mk become extravascular lung Mks, as 2/3 of lung Mks are extravascular? Or do they stay intravascular platelet producing Mks?</p></disp-quote><p>Thanks for the suggested experiments. Our revised data showed that the lung migrated MKs were extravascular lung MKs (Revised Figure 4-S6).</p><p>References</p><p>Beaulieu, L. M., Lin, E., Morin, K. M., Tanriverdi, K., and Freedman, J. E. (2011). Regulatory effects of TLR2 on megakaryocytic cell function. <italic>Blood</italic>, <italic>117</italic>(22), 5963-5974. https://doi.org/10.1182/blood-2010-09-304949</p><p>Krenkel, O., Hundertmark, J., Abdallah, A. T., Kohlhepp, M., Puengel, T., Roth, T., Branco, D. P. P., Mossanen, J. C., Luedde, T., Trautwein, C., Costa, I. G., and Tacke, F. (2020). Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis. <italic>Gut</italic>, <italic>69</italic>(3), 551-563. https://doi.org/10.1136/gutjnl-2019-318382</p><p>Markovic, B., Wu, Z., Chesterman, C. N., and Chong, B. H. (1995). Quantitation of soluble and membrane-bound Fc γ RIIA (CD32A) mRNA in platelets and megakaryoblastic cell line (Meg-01). <italic>Br J Haematol</italic>, <italic>91</italic>(1), 37-42. https://doi.org/10.1111/j.1365-2141.1995.tb05241.x</p><p>Navarro, S., Debili, N., Le Couedic, J. P., Klein, B., Breton-Gorius, J., Doly, J., and Vainchenker, W. (1991). Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. <italic>Blood</italic>, <italic>77</italic>(3), 461-471. https://www.ncbi.nlm.nih.gov/pubmed/1991163</p><p>Negrotto, S., C, J. D. G., Lapponi, M. J., Etulain, J., Rivadeneyra, L., Pozner, R. G., Gomez, R. M., and Schattner, M. (2011). Expression and functionality of type I interferon receptor in the megakaryocytic lineage. <italic>J Thromb Haemost</italic>, <italic>9</italic>(12), 2477-2485. https://doi.org/10.1111/j.1538-7836.2011.04530.x</p><p>Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J. L., Kohler, R. H., Chudnovskiy, A., Waterman, P., Aikawa, E., Mempel, T. R., Libby, P., Weissleder, R., and Pittet, M. J. (2009). Identification of splenic reservoir monocytes and their deployment to inflammatory sites. <italic>Science</italic>, <italic>325</italic>(5940), 612-616. https://doi.org/10.1126/science.1175202</p><p>Ward, J. R., Bingle, L., Judge, H. M., Brown, S. B., Storey, R. F., Whyte, M. K., Dower, S. K., Buttle, D. J., and Sabroe, I. (2005). Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. <italic>Thromb Haemost</italic>, <italic>94</italic>(4), 831-838. https://www.ncbi.nlm.nih.gov/pubmed/16270639</p><p>Xie, Y., Yin, T., Wiegraebe, W., He, X. C., Miller, D., Stark, D., Perko, K., Alexander, R., Schwartz, J., Grindley, J. C., Park, J., Haug, J. S., Wunderlich, J. P., Li, H., Zhang, S., Johnson, T., Feldman, R. A., and Li, L. (2009). Detection of functional haematopoietic stem cell niche using real-time imaging. <italic>Nature</italic>, <italic>457</italic>(7225), 97-101. https://doi.org/10.1038/nature07639</p><p>Yang, M., Li, K., Chui, C. M., Yuen, P. M., Chan, P. K., Chuen, C. K., Li, C. K., and Fok, T. F. (2000). Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression. <italic>Br J Haematol</italic>, <italic>111</italic>(1), 371-380. https://doi.org/10.1046/j.1365-2141.2000.02340.x</p></body></sub-article></article>